<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6221985</article-id><article-id pub-id-type="doi">10.3389/fmicb.2018.02597</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chander</surname><given-names>Atul Munish</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/345420/overview"/></contrib><contrib contrib-type="author"><name><surname>Yadav</surname><given-names>Hariom</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/148702/overview"/></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Shalini</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/154388/overview"/></contrib><contrib contrib-type="author"><name><surname>Bhadada</surname><given-names>Sanjay Kumar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/540752/overview"/></contrib><contrib contrib-type="author"><name><surname>Dhawan</surname><given-names>Devinder Kumar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Endocrinology, Postgraduate Institute of Medical Education and Research</institution>, <addr-line>Chandigarh</addr-line>, <country>India</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Biophysics, Panjab University</institution>, <addr-line>Chandigarh</addr-line>, <country>India</country></aff><aff id="aff3"><sup>3</sup><institution>Center for Diabetes, Obesity and Metabolism, Wake Forest School of Medicine</institution>, <addr-line>Winston-Salem, NC</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Eugenia Bezirtzoglou, Democritus University of Thrace, Greece</p></fn><fn fn-type="edited-by"><p>Reviewed by: Andrea Masotti, Bambino Ges&#x000f9; Ospedale Pediatrico (IRCCS), Italy; Gianluca Picariello, Istituto di Scienza dell&#x02019;Alimentazione (ISA), Italy; Aaron Lerner, AESKU.KIPP Institute, Germany</p></fn><corresp id="c001">*Correspondence: Sanjay Kumar Bhadada, <email>bhadadask@rediffmail.com</email> Devinder Kumar Dhawan, <email>dhawan@pu.ac.in</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>2597</elocation-id><history><date date-type="received"><day>11</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Chander, Yadav, Jain, Bhadada and Dhawan.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Chander, Yadav, Jain, Bhadada and Dhawan</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Celiac disease (CD) is an autoimmune disorder of the small intestine, caused by gluten induced inflammation in some individuals susceptible to genetic and environmental influences. To date, pathophysiology of CD in relation to intestinal microbiota is not known well. This review relies on contribution of intestinal microbiome and oral microbiome in pathogenesis of CD based on their interactions with gluten, thereby highlighting the role of upper gastrointestinal microbiota. It has been hypothesized that CD might be triggered by additive effects of immunotoxic gluten peptides and intestinal dysbiosis (microbial imbalance) in the people with or without genetic susceptibilities, where antibiotics may be deriving dysbiotic agents. In contrast to the intestinal dysbiosis, genetic factors even seem secondary in disease outcome thus suggesting the importance of interaction between microbes and dietary factors in immune regulation at intestinal mucosa. Moreover, association of imbalanced counts of some commensal microbes in intestine of CD patients suggests the scope for probiotic therapies. <italic>Lactobacilli</italic> and specific intestinal and oral bacteria are potent source of gluten degrading enzymes (glutenases) that may contribute to commercialization of a novel glutenase therapy. In this review, we shall discuss advantages and disadvantages of food based therapies along with probiotic therapies where probiotic therapies are expected to emerge as the safest biotherapies among other in-process therapies. In addition, this review emphasizes on differential targets of probiotics that make them suitable to manage CD as along with glutenase activity, they also exhibit immunomodulatory and intestinal microbiome modulatory properties.</p></abstract><kwd-group><kwd>intestinal microbiome</kwd><kwd>oral microbiome</kwd><kwd>probiotics</kwd><kwd>glutenases</kwd><kwd>functional foods</kwd><kwd>host microbe interactions</kwd></kwd-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="166"/><page-count count="16"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Celiac disease is a common autoimmune disorder of the small intestine and is manifested by intestinal inflammation, destruction of intestinal villi (villous atrophy), elongated crypts (crypt hyperplasia) (<xref rid="B133" ref-type="bibr">Schuppan et al., 2009</xref>) and altered intestinal barrier (<xref rid="B132" ref-type="bibr">Schulzke et al., 1998</xref>). CD was first reported to have prevalence 1: 184 in an Italian scholar population (<xref rid="B14" ref-type="bibr">Catassi et al., 1996</xref>). Prevalence of CD varies from 0.006 to 5.6% across different populations of world. As per recent reports, prevalence of CD in United States is 0.79% (<xref rid="B96" ref-type="bibr">Mardini et al., 2015</xref>). In European countries, its prevalence is 4% in Spain (<xref rid="B21" ref-type="bibr">Cilleruelo et al., 2015</xref>), 2.4% in Finland (<xref rid="B106" ref-type="bibr">Mustalahti et al., 2010</xref>), 0.9% in Germany (<xref rid="B84" ref-type="bibr">Laass et al., 2015</xref>), 0.6% in Northern Sweden and Hungary (<xref rid="B50" ref-type="bibr">Enroth et al., 2013</xref>; <xref rid="B7" ref-type="bibr">Burger et al., 2014</xref>), lesser in Scotland 0.01% (<xref rid="B163" ref-type="bibr">White et al., 2013</xref>) and least in Netherlands 0.006% (<xref rid="B7" ref-type="bibr">Burger et al., 2014</xref>). In Asian countries, prevalence of CD is 0.3% in Iran, 0.5% in Turkey, 0.7% in Israel (<xref rid="B139" ref-type="bibr">Shamir et al., 2002</xref>; <xref rid="B146" ref-type="bibr">Singh et al., 2015</xref>) and 0.73% across different regions of India (<xref rid="B120" ref-type="bibr">Ramakrishna et al., 2016</xref>). Saharawi population of Africa accounts 5.6% as the highest prevalence worldwide (<xref rid="B157" ref-type="bibr">Teresi et al., 2010</xref>). The presence of variant forms of human leukocyte antigen (HLA) genes are reported to be associated with the intestinal inflammation in CD but all types of genetic variations could define 48% of the disease risk thereby suggesting some other factors associated with its pathogenesis (<xref rid="B69" ref-type="bibr">Gutierrez-Achury et al., 2015</xref>). The extent of gluten intake is strongly associated with prevalence of CD rather than HLA genetics (<xref rid="B120" ref-type="bibr">Ramakrishna et al., 2016</xref>), but as gluten itself does not explain the reason for increased disease incidence and disease progression, thus environmental factors other than gluten need to be addressed (<xref rid="B118" ref-type="bibr">Pozo-Rubio et al., 2012</xref>; <xref rid="B89" ref-type="bibr">Lerner et al., 2015</xref>). In context with current scenario, intestinal dysbiosis is well reported in CD besides certain environmental factors including microbiota composition especially in infants are also associated with CD (<xref rid="B117" ref-type="bibr">Pozo-Rubio et al., 2013</xref>). Further, intestinal microbial ecology of commensals along with symbiotic and pathogenic microorganisms play an important role in pathogenesis of many gastrointestinal diseases. Intestinal bacteria interfere with the mammalian immune system and regulate differentiation of pro-inflammatory and anti-inflammatory T-cells through many pathways, among which TLR pathway (<xref rid="B124" ref-type="bibr">Round and Mazmanian, 2009</xref>; <xref rid="B15" ref-type="bibr">Cerf-Bensussan and Gaboriau-Routhiau, 2010</xref>) is a key factor for integrity and functionality of the tight junction barrier of the intestinal epithelial layer (<xref rid="B73" ref-type="bibr">Honda and Littman, 2012</xref>).</p><p>Even for several decades, CD has been known as a complex autoimmune disease. Despite knowledge about antigenic trigger, there is no successful therapy available to alter the option of Gluten Free Diet (GFD). Strict lifelong adherence to GFD always remains a challenge for patients. Further, unintentional ingestion of gluten contaminated food facilitates reoccurrence of gluten induced inflammation because intestinal microbial balance is not restored even after being on GFD (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>; <xref rid="B25" ref-type="bibr">Collado et al., 2008</xref>, <xref rid="B26" ref-type="bibr">2009</xref>). This is suggestive of persistent intestinal environment which is disease susceptible and does not allow recovery of intestinal mucosa. Probiotics are beneficial in a number of gastrointestinal disorders (<xref rid="B20" ref-type="bibr">Cheng et al., 2013</xref>; <xref rid="B34" ref-type="bibr">de Meij et al., 2013</xref>; <xref rid="B127" ref-type="bibr">Sanchez et al., 2013</xref>). This review lays emphasis on the role of oral and intestinal microbiota in pathogenesis of CD, and also elaborates on the beneficial effects of some intestinal microbes in immunomodulations as well as in detoxification of immunogenic gluten peptides. Though, genetic factors are important in pathogenesis of CD but environmental factors serve as crucial triggers for disease onset and progression.</p></sec><sec><title>Genetic Associations of CD</title><p>Involvement of HLA genes in the pathogenesis of CD is quite imminent and thus explains the risk associated with the disease. Recently, in a meta-analysis, <xref rid="B36" ref-type="bibr">De Silvestri et al. (2018)</xref> has reported that HLA-DQ genetics can even be used as a genetic screening procedure for CD children (<xref rid="B36" ref-type="bibr">De Silvestri et al., 2018</xref>). Studies across the world explain that about 40% of the risk associated with this disease depends on HLA class II region contributing to CD. Most CD subjects are HLA-DQ2 (DQA1<sup>&#x02217;</sup>05/DQB1<sup>&#x02217;</sup>02) positive (90%), while half of the remaining 10% are HLA-DQ8 (DQA<sup>&#x02217;</sup>0301/DQB1<sup>&#x02217;</sup>0302) positive (<xref rid="B151" ref-type="bibr">Sollid et al., 1989</xref>). Genetic risk due to HLA genes in CD is due to the high binding affinity of gluten peptides with DQ2/DQ8 alleles of HLA molecules.</p><p>Disease risk varies depending upon the ethnicity thereby signifying the importance of environmental factors. Involvement of risk genes in the disease pathogenesis varies with ethnicity as reported (<xref rid="B2" ref-type="bibr">Alshiekh et al., 2017</xref>). This study has shown that in a subpopulation analysis, DRB3<sup>&#x02217;</sup>01:01:02-DQA1<sup>&#x02217;</sup> 05:01-DQB1<sup>&#x02217;</sup>02:01 remained the most significant in patients with Scandinavian ethnicity whereas DRB1<sup>&#x02217;</sup>07:01:01-DRB4<sup>&#x02217;</sup>01:03:01-DQA1<sup>&#x02217;</sup>02:01-DQB1<sup>&#x02217;</sup>02:02:01 presented the highest risk of CD among non-Scandinavians. Thus, it was interpreted that different DRB1<sup>&#x02217;</sup>03:01-DQB1<sup>&#x02217;</sup>02:01 haplotypes confer different risks for CD. The associated risk of CD for DR3-DRB3<sup>&#x02217;</sup>01:01:02-DQA1<sup>&#x02217;</sup>05:01-DQB1<sup>&#x02217;</sup>02:01 is predominant among patients of Scandinavian ethnicity.</p><p>Studies in India have shown the association of HLA genes with Type 1 diabetes as well as CD (<xref rid="B138" ref-type="bibr">Serjeantson et al., 1987</xref>; <xref rid="B1" ref-type="bibr">Agrawal et al., 2000</xref>; <xref rid="B79" ref-type="bibr">Kaur et al., 2002</xref>; <xref rid="B83" ref-type="bibr">Kumar et al., 2007</xref>, <xref rid="B82" ref-type="bibr">2012</xref>; <xref rid="B100" ref-type="bibr">Mehra et al., 2007</xref>; <xref rid="B119" ref-type="bibr">Raha et al., 2013</xref>). <xref rid="B4" ref-type="bibr">Amarapurkar et al. (2015)</xref>, reported that CD in Indian patients is predominantly associated with HLA DQ 2 and DQ 8 genotypes and has high positive predictive value for diagnosis when combined with serology in symptomatic patients (<xref rid="B4" ref-type="bibr">Amarapurkar et al., 2015</xref>). While, validating the European risk loci for CD in 497 cases and 736 controls of north Indian origin, <xref rid="B135" ref-type="bibr">Senapati et al. (2015)</xref>, have reported that the north Indian population has a higher degree of consanguinity than Europeans and therefore explored the role of recessively acting variants, which replicated the HLA locus and suggested a role of additional four loci (<xref rid="B135" ref-type="bibr">Senapati et al., 2015</xref>).</p><p>In a study performed by <xref rid="B147" ref-type="bibr">Singla et al. (2016)</xref>, of 202 first-degree relatives of the 64 index cases with CD, 17.3% (35/202) were seropositive for IgA tTG while biopsy proven CD was diagnosed in 10.2% (8/78) of children and 8.1% (10/124) of adults. HLA DQ2/DQ8 was positive in 96.7% of the index cases and all first-degree relatives with confirmed CD (<xref rid="B147" ref-type="bibr">Singla et al., 2016</xref>). Another study conducted on a cohort of first degree relatives by <xref rid="B103" ref-type="bibr">Mishra et al. (2016)</xref>, has shown that prevalence of CD in first-degree relatives of CD patients was 10.9% and 87% had HLA DQ2 or DQ8 haplotype, thus concluding that all first-degree relatives of CD patients should be screened for CD even if associated with asymptomatic or with atypical manifestations. <xref rid="B152" ref-type="bibr">Srivastava et al. (2010)</xref>, in their first Asian study on a limited number of families of children with CD have reported that 4.4% of the first-degree relatives had CD whereas only 15% of the first-degree relatives were negative for HLA DQ2/DQ8 (<xref rid="B152" ref-type="bibr">Srivastava et al., 2010</xref>) and thus suggested the importance of other genetic or environmental factors in disease pathogenesis.</p></sec><sec><title>Microbes in Pathogenesis of CD</title><p>Microbiome dysbiosis in CD is reported by several studies (<xref rid="B134" ref-type="bibr">Sellitto et al., 2012</xref>). In a pursuit to explore the role of HLA genes in pathogenesis of CD, a recent report of 22 individuals genetically at risk of CD concluded that HLA-DQ2 genotype selects early intestinal microbiota composition when compared to individuals at lower genetic risk/ carriers. The individuals at high risk showed different intestinal microbiota i.e., high-risk infants had significantly less <italic>Bifidobacteria</italic> and unclassified <italic>Bifidobacteriaceae</italic> proportions and more <italic>Corynebacteria, Gemella, Clostridium sensustricto</italic>, unclassified <italic>Clostridiaceae</italic>, unclassified <italic>Enterobacteriaceae</italic> and <italic>Raoultella</italic> proportions (<xref rid="B113" ref-type="bibr">Olivares et al., 2015</xref>). On the other hand, a recent Indian study on 23,331 adults supported the importance of other factors rather than genetics because HLA genes were not associated with prevalence of CD (<xref rid="B120" ref-type="bibr">Ramakrishna et al., 2016</xref>) but the extent of gluten was. An association of microbiota with CD was first established in GFD T-CD and U-CD subjects (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>; <xref rid="B25" ref-type="bibr">Collado et al., 2008</xref>, <xref rid="B26" ref-type="bibr">2009</xref>) and thus a concept of dysbiosis was put forward. An Italian study reported that intestinal infections were strongly associated with the onset of disease and were further strongly associated with antibiotics use (<xref rid="B11" ref-type="bibr">Canova et al., 2014</xref>). Moreover, early age infections and infants&#x02019; antibiotic intake is also reported as the cause of dysbiosis and alterations in lymphocyte subpopulations (<xref rid="B117" ref-type="bibr">Pozo-Rubio et al., 2013</xref>) that can be correlated to disease activity i.e., increased cellularity (increase in number of intraepithelial lymphocytes) and atrophy of small intestinal mucosa, a characteristic feature of CD (<xref rid="B143" ref-type="bibr">Shmidt et al., 2014</xref>). Such antibiotic induced dysbiosis was characterized by decreased counts of <italic>Bifidobacterium longum</italic> and increased counts of <italic>Bacteroides fragilis</italic> (<xref rid="B117" ref-type="bibr">Pozo-Rubio et al., 2013</xref>). Moreover, dose-response relationship of antibiotics is significantly associated with onset of CD and risk of CD is further increased by cephalosporin intake (<xref rid="B11" ref-type="bibr">Canova et al., 2014</xref>). In contrast, several previous studies reported that dysbiosis in CD is characterized by decrease in <italic>Bifidobacteria</italic> counts (<xref rid="B129" ref-type="bibr">Sanz et al., 2007</xref>; <xref rid="B43" ref-type="bibr">Di Cagno et al., 2009</xref>; <xref rid="B65" ref-type="bibr">Golfetto et al., 2014</xref>; <xref rid="B63" ref-type="bibr">Giron Fernandez-Crehuet et al., 2015</xref>), pointing on antibiotics and infections as the key players of dysbiosis that may be a reason of disease susceptibility. In such a situation, a likely question arises that &#x0201c;Environmental trigger is only gluten or there is something else too i.e., microbiome dysbiosis, infections and antibiotics, or antibiotic induced dysbiosis.&#x0201d; The underlying hypothesis has been represented in the Figure <xref ref-type="fig" rid="F1">1</xref>. Intestinal microbial overgrowth is characteristic of CD and specific pathobionts namely <italic>Klebsiella oxytoca, Staphylococcus epidermidis</italic>, and <italic>S. pasteuri</italic> were reported to outnumber commensals and they have potential to exclude commensals from intestine (<xref rid="B127" ref-type="bibr">Sanchez et al., 2013</xref>). CD is a T-cell mediated disease in which gliadin-derived peptides cause inflammatory actions at intestinal epithelium thereby affecting lamina propria and T lymphocytes. Activation of T lymphocytes and other immune cells further leads to the release of proinflammatory cytokines IFN-<italic>&#x003b3;</italic> and IL-15 that are responsible for the activation of the cytotoxicity in intraepithelial lymphocytes (<xref rid="B61" ref-type="bibr">Gianfrani et al., 2005</xref>; <xref rid="B102" ref-type="bibr">Meresse et al., 2009</xref>). Studies thus suggest the imperative interaction of intestinal bacteria with immune system to direct the differentiation of both pro-inflammatory and anti-inflammatory T cell populations (<xref rid="B124" ref-type="bibr">Round and Mazmanian, 2009</xref>). The role of Regulatory T cells (Treg) has become clearer with the efforts of <xref rid="B137" ref-type="bibr">Serena et al. (2017)</xref> that help us to understand the pathogenic role of gut microbiota and their metabolites in CD through epigenetic processes. Treg cells are subset of CD4 T cells responsible for maintaining immune response to foreign antigens (<xref rid="B88" ref-type="bibr">Lehtim&#x000e4;ki and Lahesmaa, 2013</xref>). Treg cells mediate suppression of responder cells by different mechanisms (<xref rid="B115" ref-type="bibr">Pellerin et al., 2014</xref>; <xref rid="B142" ref-type="bibr">Shevach, 2018</xref>). Previous studies have reported an increase in the number of Treg cells in CD patients and suggested that functional impairments in their suppressive function may be related to the onset of the disease (<xref rid="B27" ref-type="bibr">Cook et al., 2017</xref>). The exact mechanisms that cause the altered regulatory activity of Treg cells in CD is not known. FoxP3 is a transcription factor fundamental for the suppressive function and differentiation of Treg cells. In a recent report, a higher expression of an alternatively spliced isoform of FOXP3 (FOXP3 &#x00394;2) was observed in the intestine of active CD patients as compared to non-celiac controls while no differences were seen in the expression of FOXP3 full length (FL). It suggests that altered intestinal ratio between FoxP3 isoforms may be an important indices in the pathogenesis of CD. Furthermore, higher expression of isoform FOXP3 &#x00394;2 is reported to be associated with inflammation. <italic>Ex-vivo</italic> cultures of intestinal biopsies treated with butyrate trigger a balance between FoxP3 isoforms in HC subjects, while the same does not occur in CD patients. That shows the role of microbial metabolites in modulation of splicing, thus triggering to an inflammatory state with some role in pathogenesis of CD (<xref rid="B137" ref-type="bibr">Serena et al., 2017</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Figure represents the interaction of gluten, microbes and intestinal immune regulation. Section (A) of the image represents healthy microbial ecology where there is a balance between beneficial bacteria (green) and harmful bacteria (red yellow) and beneficial microbes preventing the adhesion of harmful ones to intestinal mucosa. Section (B) represents exposure to environmental infectious agents (red) that compete with the beneficial microbes to adhere the intestinal mucosa and after adherence they disturb intestinal barrier function (tight junctions) by activating different inflammatory pathways at intestinal mucosal surface. Disturbed intestinal barrier leads to exposure of intestinal immune cells to the dietary antigens (i.e., gluten). On the other hand, infections possess elastase activity to the peptides that are more potent to translocate through intestinal barrier. These gluten peptides (blue colored) are presented by APCs to the T lymphocytes leading to cascades of immune processes leading to gluten specific immune responses and tissue remodeling to develop gluten intolerance. Section (C) highlights that the catalyst role of antibiotics that are given to patients to treat infection. Antibiotics eradicate infections along with beneficial intestinal microbes thereby leading to dysbiosis. In this condition, the opportunistic harmful microbes may prove to be dangerous because beneficial microbes can no longer protect intestinal mucosa leading to adherence of the former to the intestinal epithelial cells and creating disease susceptible microenvironment (25). Color of beneficial microbes, Green; Gluten peptides, blue colored; Color of Harmful/ Opportunist microbes,Gray colored; Color of Infections, Red colored. The arrows marking downward represent decrease in event whereas arrows marked upward represent increase in an event.</p></caption><graphic xlink:href="fmicb-09-02597-g001"/></fig><p>The increased expression of altered spliced from of FOXP3 was correlated to butyrate dependent altered intestinal micro-environment in CD patients. To the best of knowledge in the current literature, there is not a single report related to small intestinal butyrate levels of CD vs. controls. <xref rid="B137" ref-type="bibr">Serena et al. (2017)</xref> have co-related their small intestinal biopsy based concept with fecal metabolome based reported studies that looked a little controversial toward development of their hypothesis. Microbial derived metabolite in feces is not a reflection of those from small intestine because microbial communities and microbial derived metabolites differ in different parts of gut (<xref rid="B66" ref-type="bibr">Gorham et al., 2017</xref>). In this line of research, levels of butyrate in small intestine is pending to be evaluated in comparison to controls subjects. On the other hand, beneficial and detrimental effects of butyrate on the mucosal immune system are basically concentration dependent (<xref rid="B76" ref-type="bibr">Jiminez et al., 2017</xref>) and the same was not ruled out for <italic>in-vitro</italic> experiments by <xref rid="B137" ref-type="bibr">Serena et al. (2017)</xref>. Thus, at this time point, the hypothesis of detrimental effects of butyrate in CD which are mediated through splicing, may require further work.</p><sec><title>Mucosal Immunology of CD</title><p>Intestinal barrier function is associated with many autoimmune diseases and CD. Zonulin modulates the intercellular tight junctions and reversibly regulates permeability of intestine to luminal antigens and other components (<xref rid="B162" ref-type="bibr">Wang et al., 2000</xref>). Increased gene expression of zonulin is reported in CD and T1D, relating to tight junction barrier dysfunction (<xref rid="B52" ref-type="bibr">Fasano et al., 2000</xref>; <xref rid="B130" ref-type="bibr">Sapone et al., 2006</xref>). Microbes and gliadin are two important factors that upregulate the expression of zonulin leading to zonulin release from the cells (<xref rid="B155" ref-type="bibr">Sturgeon and Fasano, 2016</xref>). Administration of gliadin to the intestinal cells causes zonulin release followed by an increase in permeability. Binding of some gliadin peptides to CXCR3 receptor of enterocytes causes MyD88-dependent zonulin release. Gliadin and exposure to bacteria work in a similar manner to cause release of pro-inflammatory cytokines and zonulin from macrophages (<xref rid="B158" ref-type="bibr">Thomas et al., 2006</xref>).</p><p>Due to various etiologies, infections are important in pathogenesis of some gastrointestinal diseases. Intestinal microbes interact with immune cells and activate the inflammatory cascades through TLR pathway (<xref rid="B124" ref-type="bibr">Round and Mazmanian, 2009</xref>; <xref rid="B15" ref-type="bibr">Cerf-Bensussan and Gaboriau-Routhiau, 2010</xref>) that regulates the intestinal barrier function (<xref rid="B73" ref-type="bibr">Honda and Littman, 2012</xref>). The interaction of intestinal epithelial cells takes place with microbes residing in the gut lumen via pattern recognition receptors such as TLRs and Nod-like receptors that induce antibacterial molecules and chemokines to promote adaptive immune responses in the intestine (<xref rid="B15" ref-type="bibr">Cerf-Bensussan and Gaboriau-Routhiau, 2010</xref>). Moreover, TLR2 pathways have been reported to be involved in intestinal barrier function as mice lacking TLR2 expression are more susceptible to microbial-induced colitis (<xref rid="B73" ref-type="bibr">Honda and Littman, 2012</xref>). In addition, duodenal TLR2 expression is lower in CD subjects and higher for TLR9 as compared to HCs (<xref rid="B78" ref-type="bibr">Kalliomaki et al., 2012</xref>) thereby suggesting the involvement of microbes in inducing impairment of intestinal barrier function and immune dysregulation through TLR dysfunction. Furthermore, microorganisms stimulate IFN-&#x003b3;, TNF&#x003b1; production and activate T-cell macrophage-associated activity that may trigger a TH1-type cytokine profile (<xref rid="B92" ref-type="bibr">Li et al., 2008</xref>). Such pro-inflammatory response can contribute to an increase in the epithelial permeability that favors the access of higher antigen loads to the submucosa (<xref rid="B92" ref-type="bibr">Li et al., 2008</xref>; <xref rid="B101" ref-type="bibr">Menard et al., 2010</xref>; <xref rid="B77" ref-type="bibr">Johnston and Corr, 2016</xref>). Thus, intestinal bacteria can also regulate the ability of monocytes recruited to the mucosa to respond to gliadins and IFN-&#x003b3; in CD subjects, thereby influencing the course of the disease (<xref rid="B35" ref-type="bibr">De Palma et al., 2010</xref>). The process of autoimmunity might have resulted in epithelial stress triggered by infections, gluten peptides and inflammation. Some experimental studies further affirm the interactions between gluten, microbiota and mucosal immune dysregulation.</p><p>The composition of the intestinal microbiota affects the permeability of the intestinal mucosa and could be involved in the early stages of CD development (<xref rid="B22" ref-type="bibr">Cinova et al., 2011</xref>). Some CD infections like <italic>Pseudomonas aeruginosa</italic> directly trigger the process of inflammation as reported by <xref rid="B9" ref-type="bibr">Caminero et al. (2016)</xref>. <italic>P. aeruginosa</italic> possess elastase properties to cleave gluten peptides in such manner making them highly immunotoxic. These peptides were more potent to be translocated through the intestinal barrier and to cause activation of T-cells from CD patients (<xref rid="B9" ref-type="bibr">Caminero et al., 2016</xref>). In context to pathogenic role of some intestinal microbes in CD, simultaneous exposure of Caco-2 cells to <italic>Bacteroides fragilis</italic> and gliadin cause an increase in intestinal permeability as well as increased production of TNF&#x003b1; and IL-1&#x003b2;18 (<xref rid="B128" ref-type="bibr">Sanchez et al., 2012</xref>). After <italic>ex-vivo</italic> treatment of duodenal biopsy with gluten digest and CD associated bacteria, IL-17A responses were induced (<xref rid="B148" ref-type="bibr">Sjoberg et al., 2013</xref>) that are associated with pro-inflammatory cytokines in autoimmune and inflammatory diseases (<xref rid="B28" ref-type="bibr">Costa et al., 2010</xref>). Sequencing technologies provide the basis of host microbe interactions. Whole genome sequencing of microbes has enabled to predict pathogenic behavior of microbes (<xref rid="B17" ref-type="bibr">Chander et al., 2016a</xref>,<xref rid="B18" ref-type="bibr">b</xref>; <xref rid="B30" ref-type="bibr">D&#x02019;Argenio et al., 2016</xref>) whereas <xref rid="B30" ref-type="bibr">D&#x02019;Argenio et al. (2016)</xref> confirmed the pathogenic role of CD gut microbes by combination of <italic>in-vitro</italic> approaches. As they revealed that <italic>Neisseria flavescens</italic> species were most abundant in the symptomatic patients of CD. Genetic composition of virulence determinant genes was different in the strains of HCs compared to the diseased ones, as showed by whole genome sequence of the microbes. In addition, these strains isolated from patients, activated inflammatory responses in DCs and in <italic>ex-vivo</italic> culture of duodenal biopsies (<xref rid="B30" ref-type="bibr">D&#x02019;Argenio et al., 2016</xref>).</p><p>As the process of immune dysregulation in CD is looking to be derived from intestinal dysbiosis and infections while antibiotics act as trigger giving rise to a disease prone dysbiosis. Antibiotics not only irradiate enteric infections but are also known to exert harmful impact on beneficial gut microbes thereby causing intestinal dysbiosis. The dysbiotic microbial texture generally produces a disease prone environment. The following sections describe the types of dysbiosis caused in CD and its impact on commensal organisms.</p></sec><sec><title>Intestinal Dysbiosis in CD</title><p>In some studies, dysbiosis in CD subjects was represented by outnumbers of <italic>Bacteroides</italic> spp. and lower numbers of <italic>Bifidobacterium spp</italic>. and <italic>Bifidobacterium longum</italic>, that remained unchanged after GFD (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>; <xref rid="B25" ref-type="bibr">Collado et al., 2008</xref>, <xref rid="B26" ref-type="bibr">2009</xref>). Other studies reported increased prevalence of <italic>Bifidobacterium dentium</italic> and <italic>Bacteroides vulgatus</italic> while decreased prevalence of <italic>Bifidobacterium catenulatum</italic> and <italic>Bacteroides species</italic> (<xref rid="B25" ref-type="bibr">Collado et al., 2008</xref>; <xref rid="B126" ref-type="bibr">Sanchez et al., 2010</xref>, <xref rid="B125" ref-type="bibr">2011</xref>). During analysis of fecal microbiota in active/ symptomatic (patients presenting gastrointestinal symptoms) CD children, the levels of <italic>Bacteroides, Clostridium, Staphylococcus, C. histolyticum</italic>, Prevotella, <italic>Eubacterium rectal, C. coccoides</italic>, Atopobium, and sulfate reducing bacterial groups were reported higher (<xref rid="B24" ref-type="bibr">Collado et al., 2007</xref>). Greater prevalence of infectious microbes and gram-negative bacteria in the duodenum of celiac children was found responsible for symptomatic presentation of the disease (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>). Analyzing duodenal microbiota, T-CD patients with persistent symptoms occupy different textures of intestinal microbes in comparison with those without symptoms. Patients with persistent symptoms comprised of higher relative abundance of <italic>Proteobacteria</italic> and a lower abundance of <italic>Bacteroidetes</italic> and <italic>Firmicutes.</italic> These patients presented persistent symptoms even after following strict GFD. Comparative microbial richness in these patients was observed lesser in comparison to control subjects (<xref rid="B161" ref-type="bibr">Wacklin et al., 2014</xref>).</p><p>As per a recent report, when infants at high genetic risk were compared to those with lower risk, lower proportions of duodenal <italic>Actinobacteria</italic> and <italic>Bifidobacteria</italic> were observed in the former whereas higher proportions of <italic>Firmicutes</italic> and <italic>Proteobacteria</italic> were found in the later (<xref rid="B113" ref-type="bibr">Olivares et al., 2015</xref>). Some studies showed direct relationship of commensal bacterial groups indicating the potential therapeutic implications as described in the next sections.</p></sec><sec><title>Associations of <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> With CD</title><p>Based on the recent advancements in the molecular studies, we can clearly find a strong association of some commensal bacterial groups with CD that may conjecture about the modulation of pathogenesis of disease by them.</p><p>In some new findings, significant lower counts of <italic>Lactobacilli</italic> were found in feces of celiac children on GFD as compared to healthy children, whereas <italic>Enterobacteria</italic> were found increased in celiac children (<xref rid="B94" ref-type="bibr">Lorenzo Pisarello et al., 2015</xref>). Compared to the healthy subjects, fecal counts of <italic>Bifidobacteria</italic> were significantly higher in T-CD patients of Brazil (<xref rid="B65" ref-type="bibr">Golfetto et al., 2014</xref>). While studying the duodenal microbiota, counts of <italic>Lactobacillus</italic> were found significantly reduced as compared to the healthy individuals. CD patients were possessing <italic>Streptococcus, Bacteroides</italic> and <italic>E.coli</italic> species whereas lower counts of <italic>Streptococcus</italic> and <italic>Bacteroides</italic> were observed and numbers of <italic>Bifidobacteria, Lactobacillus</italic> and <italic>Acinetobacter</italic> were found higher in controls (<xref rid="B63" ref-type="bibr">Giron Fernandez-Crehuet et al., 2015</xref>).</p><p>The ratio of <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> to <italic>Bacteroides</italic> and <italic>Enterobacteria</italic> was lesser in T-CD subjects as compared to HCs and this difference was more when compared with U-CD subjects (<xref rid="B43" ref-type="bibr">Di Cagno et al., 2009</xref>, <xref rid="B41" ref-type="bibr">2011</xref>).</p><p>In contrast, the GFD fed CD subjects have also shown a reduction in the diversity of <italic>Lactobacillus spp.</italic> and <italic>Bifidobacterium spp.</italic> while presence of <italic>Bifidobacterium bifidum</italic> was higher in normal diet fed CD subjects than healthy adult (<xref rid="B109" ref-type="bibr">Nistal et al., 2012</xref>). <italic>Bacteroides</italic> and <italic>Escherichia coli</italic> were significantly abundant in CD patients that presented marked gastrointestinal symptoms than in controls and asymptomatic patients (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>). The ratio of beneficial microbes (<italic>Lactobacillus</italic> and <italic>Bifidobacterium)</italic> to harmful ones (<italic>Bacteroides</italic> and <italic>E. coli)</italic> was reported significantly lower in symptomatic and asymptomatic diseased subjects compared with controls (<xref rid="B107" ref-type="bibr">Nadal et al., 2007</xref>). <italic>Leuconostoc mesenteroides, Lactobacillus curvatus</italic>, and <italic>Leuconostoc carnosum</italic> species were reported as characteristic of CD subjects, while <italic>Lactobacillus casei</italic> group was characteristic of HCs while species diversity for <italic>Bifidobacterium</italic> was significantly higher in healthy children than that of CD (<xref rid="B129" ref-type="bibr">Sanz et al., 2007</xref>). It would be appropriate to conclude that decreased numbers and types of <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> strains are associated with CD and may have influence in the outcome of the disease. The results derive their implications toward therapeutic use because <italic>Lactobacilli</italic> are recently well proved for their glutenase activity and anti-inflammatory actions (<xref rid="B40" ref-type="bibr">Di Cagno et al., 2004</xref>; <xref rid="B33" ref-type="bibr">De Angelis et al., 2006</xref>; <xref rid="B45" ref-type="bibr">Duar et al., 2014</xref>).</p></sec></sec><sec><title>Interaction of Microbiota and Gluten: a Basis of Enzyme Therapy and Glutenase Therapy</title><p>Complete digestion of gluten proteins (gliadins and glutenins) is difficult by human proteolytic enzymes (<xref rid="B164" ref-type="bibr">Wieser, 2007</xref>). These proteins have been reported to possess differential immune targets that make them immunotoxic in nature (<xref rid="B13" ref-type="bibr">Caputo et al., 2012</xref>; <xref rid="B12" ref-type="bibr">Capozzi et al., 2013</xref>; <xref rid="B75" ref-type="bibr">Iacomino et al., 2013</xref>).</p><p>During proteolytic digestion in intestine, proline and glutamine rich gluten polypeptides are produced that are immunogenic and have the potential to stimulate T cells (<xref rid="B150" ref-type="bibr">Sollid and Khosla, 2005</xref>). These peptides are resistant to further hydrolysis due to enrichment of proline residues in the amino acid sequences (<xref rid="B160" ref-type="bibr">van de Wal et al., 1999</xref>; <xref rid="B5" ref-type="bibr">Arentz-Hansen et al., 2000</xref>; <xref rid="B141" ref-type="bibr">Shan et al., 2002</xref>; <xref rid="B105" ref-type="bibr">Molberg et al., 2003</xref>; <xref rid="B38" ref-type="bibr">Dewar et al., 2006</xref>; <xref rid="B145" ref-type="bibr">Siegel et al., 2006</xref>; <xref rid="B37" ref-type="bibr">De Vincenzi et al., 2010</xref>; <xref rid="B95" ref-type="bibr">Mamone et al., 2013</xref>). As most of the peptides are immunogenic in nature, some of them (p10-mer, QQPQDAVQPF) possess protective effects whereas others prevent the gliadin-dependent dendritic cell maturation (<xref rid="B62" ref-type="bibr">Giordani et al., 2014</xref>).</p><p>Some new studies further highlighted the value of gut microbes in determination of gluten immunogenicity. <italic>P. aeruginosa</italic> isolated from CD patients cleaved 33 mer peptide in such a manner that it activated gluten-specific T-cells in CD patients. On the other hand, <italic>Lactobacillus</italic> spp. isolated from the non-CD controls had potential to reduce the immunogenicity of the peptides produced by <italic>P. aeruginosa</italic> (<xref rid="B9" ref-type="bibr">Caminero et al., 2016</xref>). Looking at the necessity of degrading such peptides, an era of glutenases seems an evergreen field of research for years.</p><sec><title>Trends in Glutenases</title><p>Some studies were targeted to explore the proteolytic enzymes from sources other than bacteria that could degrade the immunogenic gliadin. An enzyme from barley, EP-B2 (glutamine-specific endoprotease) degrades complex gluten bread proteins whereas PEP from <italic>Sphingomonas capsulata</italic> detoxifies the residual oligopeptide products of EP-B2 prolyl endopeptidase. AN-PEP is also known to enhance the gluten digestion in such an excellent manner that only traces of gluten were detected in small intestine (<xref rid="B57" ref-type="bibr">Gass et al., 2007</xref>; <xref rid="B104" ref-type="bibr">Mitea et al., 2008</xref>). AN-PEP degrades T cell stimulatory peptides and gluten (<xref rid="B154" ref-type="bibr">Stepniak et al., 2006</xref>). For still better digestion of gluten, proline and glutamine specific endopeptidases from barley, fungi and bacteria were taken into account collectively by different scientific communities (<xref rid="B140" ref-type="bibr">Shan et al., 2004</xref>; <xref rid="B145" ref-type="bibr">Siegel et al., 2006</xref>; <xref rid="B154" ref-type="bibr">Stepniak et al., 2006</xref>; <xref rid="B16" ref-type="bibr">Cerf-Bensussan et al., 2007</xref>; <xref rid="B6" ref-type="bibr">Bethune and Khosla, 2012</xref>).</p><p>The use of PEPs proved extensively effective in <italic>in-vivo</italic> (animal models) and <italic>in-vitro</italic> studies (<xref rid="B70" ref-type="bibr">Hausch et al., 2002</xref>; <xref rid="B141" ref-type="bibr">Shan et al., 2002</xref>; <xref rid="B98" ref-type="bibr">Marti et al., 2005</xref>). Encouraged from these preliminary studies, present microbiota research is more emphasized on discovery of gluten degrading bacteria that might help in enzyme therapy or directly as live culture against CD.</p></sec><sec><title>Role of Oral to Intestinal Microbiota in Gluten Degradation</title><p>The oral cavity occupies protease producer microorganisms capable to hydrolyze proline and glutamine rich peptides (<xref rid="B71" ref-type="bibr">Helmerhorst et al., 2010</xref>; <xref rid="B165" ref-type="bibr">Zamakhchari et al., 2011</xref>). Salivary microorganisms exhibit glutamine endoprotease activity to degrade most of the gliadins (<xref rid="B71" ref-type="bibr">Helmerhorst et al., 2010</xref>).</p><p><italic>Rothia aeria</italic> HOT-188, <italic>Rotia mucilaginosa</italic> HOT-681, <italic>Streptococcus mitis</italic> HOT-677, <italic>Streptococcus</italic> sp. HOT-071, <italic>Actinomyces odontolyticus</italic> HOT-701, <italic>Neisseria mucosa</italic> HOT-682 and <italic>Capnocytophaga sputigena</italic> HOT-775 were the other gluten degrading bacteria identified by <xref rid="B53" ref-type="bibr">Fernandez-Feo et al. (2013)</xref>. <italic>R. mucilaginosa</italic> and <italic>R. aeria</italic> are highly active toward gluten and are able to cleave 33-mer and 26-mer immunogenic peptides. Interestingly, the enzyme produced by <italic>R. aeria</italic> is active over a wide pH range (pH 3&#x02013;10) of intestinal pH (<xref rid="B165" ref-type="bibr">Zamakhchari et al., 2011</xref>).</p><p>In addition, salivary microbiota and metabolome are reported to be associated with CD (<xref rid="B54" ref-type="bibr">Francavilla et al., 2014</xref>). Despite of significance of oral microbiota in gluten degradation, <xref rid="B10" ref-type="bibr">Caminero et al. (2014)</xref>, gained attention by certifying the significance of intestinal/ duodenal microbiota in metabolism of proteins that is also a valuable work. <italic>Lactobacillus helveticus</italic> is known to efficiently cleave the long immunogenic peptides (<xref rid="B19" ref-type="bibr">Chen et al., 2003</xref>). <xref rid="B10" ref-type="bibr">Caminero et al. (2014)</xref> reported 144 strains of 35 bacterial species exhibiting the property of gluten metabolism. Most of these strains were from phyla Firmicutes and Actinobacteria. Exploring the role of duodenal microbes in gluten degradation, their group discovered 31 strains with extracellular proteolytic activity against gluten and 27 other strains had peptidolytic activity against the 33-mer peptide (<xref rid="B72" ref-type="bibr">Herran et al., 2017</xref>).</p><p>A mixture of <italic>Lactobacilli</italic> and fungal proteases were studied to demolish the immunogenicity of wheat by long-time fermentation and 33-mer peptide was efficiently hydrolyzed by <italic>Lactobacilli</italic> (<xref rid="B122" ref-type="bibr">Rizzello et al., 2007</xref>).</p><p>On the footsteps of traditional trends in glutenases, modern research is promoting to commercialize the glutenases into action. <xref rid="B131" ref-type="bibr">Savvateeva et al. (2015)</xref>, proved that recombinant wheat cysteine protease triticain-&#x003b1; exhibited glutenase and collagenase activities that is stable at intestinal pH and was potent to hydrolyze immunotoxic gluten peptides. In a phase 2 trial, glutenase ALV003 successfully attenuated mucosal injury in CD patients consuming upto 2 g gluten daily along with GFD (<xref rid="B85" ref-type="bibr">Lahdeaho et al., 2014</xref>). Approaches to screen gluten degrading bacteria are still in fast progression. <italic>Lactobacillus ruminis, Lactobacillus johnsonii, Lactobacillus amylovorus, Lactobacillus salivarius</italic> bacteria comprises of high peptide-degrading properties. All the strains possessed different degradation rates and cleavage patterns capable of reducing immunotoxic gluten peptides but were not efficient for complete removal of peptides (<xref rid="B46" ref-type="bibr">Duar et al., 2015</xref>).</p></sec></sec><sec><title>Gut Flora Modulation: Impact on CD</title><p>Now CD is known for overgrowth of pathogenic microbes that dominates to symbionts thereby excluding the later from intestinal ecosystem (<xref rid="B127" ref-type="bibr">Sanchez et al., 2013</xref>). Administration with some probiotics either alters the intestinal microbiome composition or brings about some health beneficial immunomodulations. As described here, the gut flora modulation proved to be beneficial when trials were conducted in different <italic>in-vitro</italic> and <italic>in-vivo</italic> models and somehow in human trials also.</p><sec><title>Probiotics</title><p>Probiotics are live microorganisms that provide health beneficial impact on host when administered in adequate amounts (<xref rid="B68" ref-type="bibr">Guarner et al., 2005</xref>). Reports showing probiotic induced beneficial effects in animal models of CD certify that probiotics have a positive influence on disease pathology through different mechanisms. Down-regulation of pro-inflammatory biomarkers, expression of NF-kB, TNF-&#x003b1;, and IL-1&#x003b2; was modulated in cell culture experiments after administration with <italic>Bifidobacteria</italic> (<xref rid="B87" ref-type="bibr">Laparra and Sanz, 2010</xref>; Table <xref rid="T1" ref-type="table">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Differential mode of action of probiotics in gluten induced immunotoxicity.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Probiotic used</th><th valign="top" align="left" rowspan="1" colspan="1">Model used</th><th valign="top" align="left" rowspan="1" colspan="1">Mode of sensitization</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th><th valign="top" align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Bifidobacterium longum</italic> CECT 7347</td><td valign="top" align="left" rowspan="1" colspan="1">Female, weaning Wistar rats</td><td valign="top" align="left" rowspan="1" colspan="1">IFN-<italic>&#x003b3;</italic> and fed gliadin</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Bifidobacterium longum</italic> attenuates the production of inflammatory cytokines and the CD4 + T-cell mediated immune response.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B86" ref-type="bibr">Laparra et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lactobacillus casei</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Transgenic mice expressing the human DQ8 heterodimer</td><td valign="top" align="left" rowspan="1" colspan="1">Chymotryptic digest of gliadin along with cholera toxin</td><td valign="top" align="left" rowspan="1" colspan="1">Enhanced the gliadin specific response mediated by CD4 + T cells.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B31" ref-type="bibr">D&#x02019;Arienzo et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Saccharomyces boulardii</italic> KK1 strain</td><td valign="top" align="left" rowspan="1" colspan="1">BALB/c mice</td><td valign="top" align="left" rowspan="1" colspan="1">Gluten-containing commercial food pellets</td><td valign="top" align="left" rowspan="1" colspan="1">Improved enteropathy development in association with decrease of epithelial cell CD71 expression and local cytokine production.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B114" ref-type="bibr">Papista et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Bifidobacterium longum</italic> CECT 7347</td><td valign="top" align="left" rowspan="1" colspan="1">Female weanling Wistar rats</td><td valign="top" align="left" rowspan="1" colspan="1">Gliadin</td><td valign="top" align="left" rowspan="1" colspan="1">Ameliorate the inflammation caused by gliadin.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B112" ref-type="bibr">Olivares et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lactobacillus casei</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Transgenic mice expressing the HLA-DQ8 molecule in the absence of endogenous mouse class II genes, non transgenic for human CD4.</td><td valign="top" align="left" rowspan="1" colspan="1">Wheat gliadin</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. casei</italic> can be effective in rescuing the normal mucosal Architecture.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B32" ref-type="bibr">D&#x02019;Arienzo et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Probiotic Based Approaches and Tolerance Induction</title><p>A strategy used to induce suppression of immune responses to an antigen to develop tolerance for the same antigen is known as tolerance induction. Different approaches for tolerance induction were used. Recombinant alpha-gliadin protein was used for the potential immunomodulation of this disease. Intranasal administration of recombinant alpha-gliadin in DQ8 transgenic mice induced downregulation of immune responses against gliadin (<xref rid="B136" ref-type="bibr">Senger et al., 2003</xref>). Another study was emphasized on oral tolerance that is the induction of antigen-specific suppression of immune responses to an antigen by its prior oral feeding. <italic>Lactobacillus lactis</italic> was genetically engineered for secretion of a DQ8 specific gliadin epitope. Oral administration of this bacteria suppressed DQ8 restricted T-cell responses in NOD AB&#x000b0; DQ8 transgenic mice (<xref rid="B74" ref-type="bibr">Huibregtse et al., 2009</xref>). This might be a promising therapeutic approach for treatment of CD and may prove to be helpful to prevent CD in DQ8 associated genetically susceptible individuals.</p><p><italic>Saccharomyces boulardii</italic> KK1 strain had exhibited capability to hydrolyse the 28-kDa alpha-gliadin fraction, and when fed to mice, attenuated enteropathy development as well as caused decreased expression of epithelial cell CD71 + cells and cytokines (<xref rid="B114" ref-type="bibr">Papista et al., 2012</xref>). However, administration of the <italic>Bifidobacterium longum</italic> CECT 7347 alone to rats fed gliadins ameliorated the inflammation caused by gliadin feeding (<xref rid="B112" ref-type="bibr">Olivares et al., 2012</xref>). Recently, <xref rid="B3" ref-type="bibr">Alvarez-Sieiro et al. (2014)</xref>, designed two food-grade <italic>Lactobacillus casei</italic> strains by genetic engineering that could deliver PEP. Out of these two, one was capable to secrete PEP into the extracellular medium whereas the other was able to maintain PEP in the intracellular environment (<xref rid="B3" ref-type="bibr">Alvarez-Sieiro et al., 2014</xref>). The strain was most effective to degrade 33-mer peptide and was resistant to simulated gastrointestinal stress. Further, pre-clinical trials of these strains are still pending that need to confirm their actions against gluten.</p></sec><sec><title>Probiotics and Clinical Trials in CD Patients</title><p>Inspite of a number of <italic>in-vitro</italic> and <italic>in-vivo</italic> preclinical studies on probiotics in CD, there are scarcely available data for human trials. An exploratory trial of probiotic <italic>Bifidobacterium infantis</italic> natren life start strain was proved to alleviate symptoms in untreated CD but was not beneficial to strengthen intestinal permeability (<xref rid="B149" ref-type="bibr">Smecuol et al., 2013</xref>). The effects of this probiotic proved helpful for U-CD patients with regard to gastrointestinal symptoms and serological markers. Similarly, a recent double blind randomized-placebo controlled intervention trial of <italic>Bifidobacterium longum</italic> CECT 7347 improved growth related parameters in Spanish children under study thereby improving the efficacy of GFD (<xref rid="B111" ref-type="bibr">Olivares et al., 2014</xref>). This strain affected lymphocyte subsets which might contribute to recovery from mucosal inflammation. Administration of this probiotic modulated the intestinal microbiota with decrease in total copy number of microbes and decrease in <italic>Bacteroids fragilis</italic> that further correlated with decrease in secretory IgA evaluated from stool samples. These correlations presented the recovery of intestinal mucosa after administration of <italic>B. longum.</italic> Probiotic intervention with two strains, <italic>Bifidobacterium breve</italic> BR03 and <italic>Bifidobacterium breve</italic> B632 was given to CD patients in a very recent study (<xref rid="B81" ref-type="bibr">Klemenak et al., 2015</xref>). This 3 months intervention depicted a positive effect in decreasing TNF&#x003b1; production in CD children on GFD and the effect was reversed after 3 months of trial. Along with advancement in probiotic therapies, helminth therapy is also emerging as a fruitful outcome of research on host microbe interactions (<xref rid="B60" ref-type="bibr">Giacomin et al., 2015</xref>). During this trial of experimental hookworm infection in subjects, intestinal microbiota structure was preserved with increase in microbial species richness even when challenged with moderate gluten. This study revealed that gluten-induced inflammation can be regulated by hookworms (<xref rid="B60" ref-type="bibr">Giacomin et al., 2015</xref>).</p></sec></sec><sec><title>Other Environmental Factors</title><p>The topics discussed in this section are in a stage of infancy in literature but have serious associations with human health (<xref rid="B91" ref-type="bibr">Lerner et al., 2017</xref>). Future studies may further validate these concerns to clarify their real picture in disease pathogenesis.</p><sec><title>Probiotics and Antibiotic Resistance Genes</title><p>Gene flux in bacteria is well reported (<xref rid="B29" ref-type="bibr">Courvalin, 2008</xref>) and plasmids of lactic acid producing bacteria contain genes responsible for resistance to tetracycline, erythromycin, chloramphenicol, lincosamide, macrolides, streptomycin, and streptogramins (<xref rid="B29" ref-type="bibr">Courvalin, 2008</xref>). Administration of probiotics to the patients may lead to transfer of this resistant gene pool to other microbial communities via horizontal gene transfer. There are several hypotheses about this concept demanding a valid study to reach a conclusion. Some studies have tried to address this controversy with compromised outcomes (<xref rid="B48" ref-type="bibr">Duranti et al., 2017</xref>) and another study has evaluated that the transfer of a tetracycline resistance gene from probiotic <italic>L. reuteri</italic> to bacteria in the human gut was not observed (<xref rid="B49" ref-type="bibr">Egervarn et al., 2010</xref>). To better clarify the hypothesis, a well-planned study similar to that of <xref rid="B49" ref-type="bibr">Egervarn et al. (2010)</xref> is required so as to explore the exact impact of using probiotics on resistome of human gut microbiota.</p></sec><sec><title>Microbial Transglutaminase: Cause or Consequence of CD</title><p>Microbial transglutaminase (mTG) is used in the food industry for many functions. It has considerable potential to improve the texture, viscosity, elasticity and water-binding capacity of food products and is used on a large scale for better fermentation tolerance in baked goods such as breads, pastas, pastries, and tortillas (<xref rid="B80" ref-type="bibr">Kieliszek and Misiewicz, 2014</xref>). Transglutaminase is hypothesized as a direct modulator of gut permeability that acts by crosslinking tight junction proteins in the epithelial cells, but its effectiveness has not been proved, as yet. Here was the sense of overestimating mTG over the gliadin (<xref rid="B90" ref-type="bibr">Lerner and Matthias, 2015</xref>), because gliadin itself is such a strong immunotoxic agent that can disrupt tight junction assembly of epithelial cells. mTG crosslinks numerous ingredients in the food industry, emulsifying them and potentially facilitate their passage through the tight junction (<xref rid="B90" ref-type="bibr">Lerner and Matthias, 2015</xref>). Thus, this property of mTG can be correlated with cross-linking of gluten peptides that can facilitate their passage through the tight junctions. The concept about mTG to cross-link, emulsify and throw the tight junction proteins out, need to be validated yet. To the best of literature search, except for the hypothesized theories and predictions, emulsifiers are not experimentally proved to affect the tight junction leakage till date, instead emulsifiers/ mTG might have allowed passage of gluten, other antigens and food ingredients from the intestinal lumen in order to produce inflammation and thus tight junction dysfunction. At present, there is an urgent need to clarify this controversy of mTG in relation to CD pathogenesis. So, if it is not evidence based, before hypothesizing such a fact, there might be a need of clarity about the amount of enzyme activity left after fermentation and other industrial processes. So the questions may arise in context with whether this enzyme remain active even after industrial go through and is also able to tolerate variable pH from mouth to small intestine to remain active in intestinal micro-environment so as to cause damage to human intestine? Further, animal studies or <italic>in-vitro</italic> studies may be planned to check the role of gliadins in the presence or absence of mTG and evaluating the gene expression of inflammatory and tight junction proteins in intestinal cells and such studies would be an important step forward.</p><p>An important study has recently unraveled immunological responses caused by mTG in CD patients (<xref rid="B99" ref-type="bibr">Matthias et al., 2016</xref>) and has shown the importance of mTG as an immunogenic agent for CD patients. For the first time, they report that mTG stimulates human immune system to produce specific antibodies. Importantly, immunogenicity of those antibodies was reported only in CD patients and not in nonceliac, symptomatic children, pediatric and adult control groups. Although, anti mTG neo-epitope antibodies levels positively correlate to the degree of the intestinal injury in CD but it cannot be interpreted that mTG is the cause of injury. Rather, it can be concluded that mTG ingested via food products get exposed to the immune cells in gliadin/ dysbiosis induced inflamed intestine of CD patients. Thus, immune response produced against mTG might leads to production of specific antibodies that are reported by <xref rid="B99" ref-type="bibr">Matthias et al. (2016)</xref> in CD patients but not in controls. Therefore, mTG or mTG induced immune responses as a cause or a consequence of CD, needs to be validated further.</p></sec></sec><sec><title>Functional Foods</title><p>Since, probiotic bacteria are known to have protective effects in different manners, thus these are expected to ferment the foods that can be safe for CD patients. Functional foods are the foods with health-promotion or disease prevention effects that include processed food or foods prepared with health-promoting additives (<xref rid="B108" ref-type="bibr">Nagpal et al., 2012</xref>). Fermented foods with live cultures are also considered functional foods with probiotic benefits (<xref rid="B153" ref-type="bibr">Stanton et al., 2005</xref>).</p><p>Lactic acid bacteria under specific processing conditions have the capacity to effectively hydrolyse the major gluten protein gliadin (<xref rid="B40" ref-type="bibr">Di Cagno et al., 2004</xref>; <xref rid="B33" ref-type="bibr">De Angelis et al., 2006</xref>). Selected bacteria <italic>Lactobacillus sanfranciscensis</italic> 7A, <italic>Lactobacillus alimentarius</italic> 15M, <italic>Lactobacillus hilgardii</italic> 51B and <italic>Lactobacillus brevis</italic> 14G completely hydrolyzed gliadins during fermentation of a mixture of millet and buckwheat flours, wheat and non-toxic oat (<xref rid="B40" ref-type="bibr">Di Cagno et al., 2004</xref>). Forty-six strains of sourdough LAB were also screened for their proteolytic activity and the sourdough cultures with <italic>Lactobacillus sanfranciscensis</italic> LS40, LS41, <italic>Lactobacillus plantarum</italic> CF1 were used for the manufacture of gluten free bread (<xref rid="B42" ref-type="bibr">Di Cagno et al., 2008</xref>). Studies have shown that the proteolytic action of bacteria can eliminate traces of gluten component from the contaminated gluten free food products (<xref rid="B64" ref-type="bibr">Gobbetti et al., 2007</xref>). Several strains worked differently to degrade 31&#x02013;43 and 62&#x02013;75 alpha-gliadin fragments, whereas the 57&#x02013;89 peptide degradation depends upon their genetic information to produce peptidases (<xref rid="B58" ref-type="bibr">Gerez et al., 2008</xref>). Trials of fermented foods in CD subjects were also proved safe with recovery from intestinal inflammation (<xref rid="B8" ref-type="bibr">Calasso et al., 2012</xref>; <xref rid="B39" ref-type="bibr">Di Cagno et al., 2010</xref>). A 60-day baked diet made from hydrolyzed wheat flour with sourdough <italic>Lactobacilli</italic> and fungal proteases was not toxic to subjects with CD (<xref rid="B67" ref-type="bibr">Greco et al., 2011</xref>). The digestion of protein increased when fermentation is followed by use of intermediate content of gluten rather than whole gluten (<xref rid="B121" ref-type="bibr">Rizzello et al., 2014</xref>). The probiotic VSL#3 also decreased the toxicity of wheat flour when fermented for a longer duration (<xref rid="B33" ref-type="bibr">De Angelis et al., 2006</xref>). Gliadins predigested by VSL#3 lead decreased intestinal mucosal permeability by decreasing reorganization of the F-actin (<xref rid="B23" ref-type="bibr">Clemente et al., 2003</xref>; <xref rid="B44" ref-type="bibr">Drago et al., 2006</xref>). Inspite of extensive research on glutenases and fermented products to reduce/ elininate gluten content, there is lack of such products in market. The reason may rely in the safety of such products because even the traces of left over gluten escaping the fermentation may be harmful for patients. Such controversy was reported in the pilot study conducted by <xref rid="B39" ref-type="bibr">Di Cagno et al. (2010)</xref> in which eight patients were challenged with daily consumption of 200 g of wheat baked goods equivalent to 10 g of native gluten. Subsequently, out of these eight patients, 1 patient interrupted the trial after 15 days and another has done so after 30 days only due to difficulties in the compliance of the daily consumption (<xref rid="B39" ref-type="bibr">Di Cagno et al., 2010</xref>). This study concluded that the product was safe except for one patient who could not continue the trial. Another study also had similar findings that some of the patients could not complete a trial of baked goods for 2 months. Some patients discontinued the trial due to disease symptoms or other had developed subtotal villus atrophy (<xref rid="B67" ref-type="bibr">Greco et al., 2011</xref>). The reason for lack of commercialization of such products may be due to excecution of formal trials for a longer duration even for more than 2 month period. Moreover, the products do not look safe untill there is complete elimination of gluten content from such products. The quality check of such baked products should be strict enough to valiadte the comlete eliminiation of gluten content from the wheat.</p><p>Thus, relatively, the development of gluten free cereals or use of pseudocereals will be most relevant to maintain nutritional values and safety for T-CD subjects. Further, the use of enzyme therapies or functional foods may prove to be harmful because even traces of gluten peptides, if left undigested in a fermented product, may lead to reoccurrence of disease in the CD patients.</p></sec><sec><title>Prospective and Conclusion</title><p>CD is caused by interplay between gluten, genetic factors and environmental factors (gut microbiota). Genetic factors proved to be associated with CD in a country may not define the disease risk in other country. It was reported that children possessing HLA haplotype DR3&#x02013;DQ2 or DR4&#x02013;DQ8 are at increased risk of CD. The relative disease risk imparted by such genes was reported more in Sweden than in United States, Finland and Germany. This highlights the importance of environmental factors in development and pathogenesis of CD (<xref rid="B93" ref-type="bibr">Liu et al., 2014</xref>). This fact is deriving attention toward the importance of factors other than genetic factors as a disease trigger. Such factors can be different dietary habits of different populations. As gluten is the causal antigen responsible for CD, the populations relying upon gluten diets may have greater risk of disease development. Data is scarce on this part of controversy, but depending upon existing literature, it can be hypothesized that environmental factor (GI infections, antibiotics, intestinal dysbiosis) allow gluten to trigger CD irrespective of genetic factors. In the absence of gluten, the effect of such environmental factors for development of CD is less or negligible where wheat is not a staple food. India is a diverse country and different geographical regions have different dietary habits. Wheat is the staple food for north Indian population, whereas north-east Indian population rely on rice, south Indian population rely on rice based products and sea foods. Thus, accordingly is the prevalence of CD in different populations of India. Mean daily wheat intake was highest in northern (455 g) compared with northeastern (37 g) or southern part (25 g), whereas daily rice intake showed an inverse pattern. The population prevalence of genes determining HLA-DQ2 and/or -DQ8 expression was 38.1% in northern, 31.4% in northeastern, and 36.4% in southern India. The prevalence of celiac autoantibodies was observed 1.23% in north India, 0.87% in north east India, and 0.10% in south India (<italic>P</italic> &#x0003c; 0.0001). Such diversity in dietary habits is not reported as much as in India than in other populations of the world so the phenomenon may not be observed well in other populations of world or there is lack of such well planned prevalence study based on dietary habits and risk genetic factors. In this recent study from different regions of India, gluten intake was correlated to prevalence of CD instead of HLA genetics (<xref rid="B120" ref-type="bibr">Ramakrishna et al., 2016</xref>). It can be concluded that there might be the additive effects of gluten and infection or antibiotic induced dysbiosis that interfere with mucosal immune homeostasis to develop this complex disorder (Figure <xref ref-type="fig" rid="F2">2</xref>). Although, a different pattern of prevalence of CD was also obsereved in different European countries i.e., 4% in Spain (<xref rid="B21" ref-type="bibr">Cilleruelo et al., 2015</xref>), 2.4% in Finland (<xref rid="B106" ref-type="bibr">Mustalahti et al., 2010</xref>), 0.9% in Germany (<xref rid="B84" ref-type="bibr">Laass et al., 2015</xref>), 0.6% in Northern Sweden and Hungary (<xref rid="B50" ref-type="bibr">Enroth et al., 2013</xref>; <xref rid="B7" ref-type="bibr">Burger et al., 2014</xref>), lesser in Scotland 0.01% (<xref rid="B163" ref-type="bibr">White et al., 2013</xref>) and least in Netherlands 0.006% (<xref rid="B7" ref-type="bibr">Burger et al., 2014</xref>) but in these countries, the hypothesis of environmental factors may not be validated due to lack of well planned studies emphasized on dietary habits and genetics in relation to disease prevalence.</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Diagrammatic representation of microenvironment proposed for CD development. Infections and antibiotic intake produce CD prone environment that affects commensals communities. Decreased number and diversity of commensals results in immune dysregulation because lesser numbers of commensals (microbes secreting glutenases) may lead to inefficient gluten digestion followed by decreased intestinal barrier function and leaving behind significant amount of intact immunotoxic peptides for immune activation. The arrows marking downward represent decrease in event whereas arrows marked upward represent increase in an event.</p></caption><graphic xlink:href="fmicb-09-02597-g002"/></fig><p>Human leukocyte antigen and non-HLA genes are best used to identify individuals at risk of CD (<xref rid="B123" ref-type="bibr">Romanos et al., 2009</xref>), but genetics in CD, either defined by HLA or non-HLA genes seems secondary to the environmental factors. Therefore, the environmental factors that influence gut barrier integrity might have primary role in incidence, progression and management of CD rather than genetics (Figure <xref ref-type="fig" rid="F1">1</xref>). Apart from this, gluten is considered as environmental trigger of the disease whereas infections and use of antibiotics need to be addressed equally as important factors in pathogenesis of CD.</p><sec><title>Clinical Implications</title><p>Infections and antibiotic treatment in the early stages of life is the contributing factor for dysbiosis, as a trigger for CD (<xref rid="B22" ref-type="bibr">Cinova et al., 2011</xref>; <xref rid="B117" ref-type="bibr">Pozo-Rubio et al., 2013</xref>; <xref rid="B127" ref-type="bibr">Sanchez et al., 2013</xref>; <xref rid="B11" ref-type="bibr">Canova et al., 2014</xref>; <xref rid="B143" ref-type="bibr">Shmidt et al., 2014</xref>), that may be reversed by modulating gut microbiota. Decreased number of <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> were reported in CD as compared to healthy individuals, where the former has potential to degrade immunotoxic peptides of gliadin while later is well known for its protective effects exerted on gliadin induced inflammation. Therefore, imbalance with these bacterial species can be supposed to influence gluten digestion and inflammatory state of intestine (Table <xref rid="T1" ref-type="table">1</xref>).</p><p>Apart from intestinal microbiome, some reports about oral microbiome prove its crucial role in the digestion of dietary gluten (<xref rid="B71" ref-type="bibr">Helmerhorst et al., 2010</xref>; <xref rid="B165" ref-type="bibr">Zamakhchari et al., 2011</xref>; <xref rid="B53" ref-type="bibr">Fernandez-Feo et al., 2013</xref>). Oral microbiome might be a determining factor for composition of intestinal microbiome. In addition, very recently <xref rid="B54" ref-type="bibr">Francavilla et al. (2014)</xref> reported that salivary microbiota is associated with CD (<xref rid="B54" ref-type="bibr">Francavilla et al., 2014</xref>), so the role of oral microbiota as the gluten degraders cannot be ignored.</p><p>Celiac disease is now well studied for oral and intestinal dysbiosis. In such a condition, it is advisable that along with GFD, administrating the subjects with probiotics may help in improving intestinal barrier function by immunomodulations as well as gut microbiota modulations, improving quality of life because GFD itself cannot restore intestinal microbiome (<xref rid="B161" ref-type="bibr">Wacklin et al., 2014</xref>) and small-intestinal mucosa (<xref rid="B159" ref-type="bibr">Tuire et al., 2012</xref>). In contrast, probiotics may suppress disease complications in U-CD subjects also because LABs may act to degrade immunotoxic gluten peptides, thereby creating tolerance to gluten. Another aspect, that short chain fatty acids produced by LABs possess anti-inflammatory potential, potential of intestinal barrier function restoration and potential to modulate regulatory T cell function at intestinal mucosa (<xref rid="B97" ref-type="bibr">Mariadason et al., 1997</xref>; <xref rid="B116" ref-type="bibr">Peng et al., 2007</xref>; <xref rid="B56" ref-type="bibr">Furusawa et al., 2013</xref>). At present, instead of enzyme therapies and other approaches, probiotic therapy seems as the most applicable and safe biotherapy like a multipurpose sword against CD.</p></sec></sec><sec><title>Critical Appraisal of Study and Future Research Targets</title><p>Microbes, now an important part in pathology of U-CD and T-CD patients but rare efforts have been made to modulate the intestinal microbiota in a health favorable manner (<xref rid="B47" ref-type="bibr">Duenas et al., 2015</xref>). Diet is the modulator of gut microbiota (<xref rid="B59" ref-type="bibr">Ghosh et al., 2014</xref>; <xref rid="B110" ref-type="bibr">Ojeda et al., 2015</xref>), but except several reports on pre and post GFD examination of gut microbiota, lesser is known about the modulation in dietary therapy and its impact on intestinal microbes. Although, sequencing technologies have been frequently manipulated to understand diet-microbe interactions and its effects on host physiology (<xref rid="B156" ref-type="bibr">Suez et al., 2014</xref>) but in CD it needs more advancements. For example, according to a very recent report, effect of an Italian-style GFD was observed in the patients who were following African-style GFD for at least 2 years. Salivary microbiota and metabolome were observed with significant differences suggesting about metabolic dysfunction after switching to Italian-style dietary habits. This switching had lead to enrichment of <italic>Granulicatella, Porphyromonas</italic> and <italic>Neisseria</italic> while decreased counts of <italic>Clostridium, Prevotella</italic> and <italic>Veillonella</italic> (<xref rid="B51" ref-type="bibr">Ercolini et al., 2015</xref>). At present, as GFD is the only option for patients, therefore, efforts should be made to modulate the GFD in such a manner that it should promote the growth of beneficial microbes and should promote a better host metabolic control rather than growth of pathogens leading to metabolic deregulation. By modulating the GFD, post-GFD complications may also be best managed and GFD may remain as the best treatment option of CD ever. The kind of diet based interventions being used by <xref rid="B51" ref-type="bibr">Ercolini et al. (2015)</xref> are not related to the risk of horizontal gene transfer and antibiotic resistance that may be a probable outcome of using probiotics. Some of the diet interventions may shift the microbial balance in a positive way thereby encouraging the growth of beneficial microbes with simultaneous decrease in the counts of pathogens. Specific dietary approaches or prebiotics will only encourage the growth of indigenous beneficial microbes and is an approach step forward to the probiotics.</p><p>A combination of probiotics having specific properties can be recommended because as per the reported human trials, patients were administered with strains of <italic>Bifidobacteria</italic> only (<xref rid="B149" ref-type="bibr">Smecuol et al., 2013</xref>; <xref rid="B111" ref-type="bibr">Olivares et al., 2014</xref>; <xref rid="B81" ref-type="bibr">Klemenak et al., 2015</xref>), but different microbes possessing specific beneficial properties and glutenase producing microbes should be included in a panel of probiotic supplement to achieve desired goals.</p><p>As microbial dysbiosis is reported by several studies in CD (<xref rid="B134" ref-type="bibr">Sellitto et al., 2012</xref>), with an aim to find dysbiosis as a cause or consequence of disease, from a subset of 22 at risk individuals. It has been concluded that HLA-DQ2 genotype selects early intestinal microbiota composition in infants at high risk of developing CD (<xref rid="B113" ref-type="bibr">Olivares et al., 2015</xref>) but a recent Indian study on 23,331 adults supported the importance of other factors rather than genetics, in which HLA genes were not associated with prevalence of disease (<xref rid="B120" ref-type="bibr">Ramakrishna et al., 2016</xref>). To better understand the controversial status and contribution of interacting environmental factors, microbiota and host genetics in CD, future research in this area should focus on the impact of a change in particular type of microbiota on disease specific markers in individuals with and without genetics susceptibilities. In this pursuit, whole genome sequencing of microbes, metagenomics and transcriptomics would be helpful (<xref rid="B55" ref-type="bibr">Franzosa et al., 2014</xref>). In addition, prevalence and types of infections associated with CD need to be explored. The future studies should evaluate the impact of such infections on disease outcome (<xref rid="B144" ref-type="bibr">Shoaie et al., 2015</xref>). Impact of different types of antibiotics in creating disease susceptible environment should be focused for clarity on the role of environmental factors. Due to some prime importance, the role of specific biologically active dietary components can also be studied in ameliorating the effects of dysbiosis (<xref rid="B166" ref-type="bibr">Zhou et al., 2015</xref>).</p></sec><sec><title>Author Contributions</title><p>AC wrote the article. HY and SJ proposed and helped in editing this article. SB and DD edited the article. All authors have read and approved the final manuscript.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>AC is grateful to Indian Council of Medical Research (ICMR), New Delhi, and DST-PURSE, India.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Yachha</surname><given-names>S. K.</given-names></name><name><surname>Muller-Myhsok</surname><given-names>B.</given-names></name><name><surname>Mehrotra</surname><given-names>P.</given-names></name><name><surname>Agarwal</surname><given-names>S. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Association of human leucocyte-DR and DQ antigens in coeliac disease: a family study.</article-title>
<source><italic>J. Gastroenterol. Hepatol.</italic></source>
<volume>15</volume>
<fpage>771</fpage>&#x02013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1046/j.1440-1746.2000.02227.x</pub-id>
<?supplied-pmid 10937683?><pub-id pub-id-type="pmid">10937683</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshiekh</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Lernmark</surname><given-names>&#x000c5;.</given-names></name><name><surname>Geraghty</surname><given-names>D.</given-names></name><name><surname>Naluai</surname><given-names>&#x000c5;.</given-names></name><name><surname>Agardh</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Different DRB1<sup>&#x02217;</sup> 03: 01-DQB1<sup>&#x02217;</sup> 02: 01 haplotypes confer different risk for celiac disease.</article-title>
<source><italic>Hla</italic></source>
<volume>90</volume>
<fpage>95</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1111/tan.13065</pub-id>
<?supplied-pmid 28585303?><pub-id pub-id-type="pmid">28585303</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Sieiro</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>M. C.</given-names></name><name><surname>Redruello</surname><given-names>B.</given-names></name><name><surname>Del Rio</surname><given-names>B.</given-names></name><name><surname>Ladero</surname><given-names>V.</given-names></name><name><surname>Palanski</surname><given-names>B. A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Generation of food-grade recombinant <italic>Lactobacillus casei</italic> delivering <italic>Myxococcus xanthus</italic> prolyl endopeptidase.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>98</volume>
<fpage>6689</fpage>&#x02013;<lpage>6700</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-5730-7</pub-id>
<?supplied-pmid 24752841?><pub-id pub-id-type="pmid">24752841</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amarapurkar</surname><given-names>D. N.</given-names></name><name><surname>Somani</surname><given-names>V. S.</given-names></name><name><surname>Shah</surname><given-names>A. S.</given-names></name><name><surname>Kankonkar</surname><given-names>S. R.</given-names></name></person-group> (<year>2015</year>). <article-title>HLA - DQ genotyping in celiac disease in western India</article-title>. <source><italic>Trop. Gastroenterol.</italic></source>
<volume>36</volume>
<fpage>174</fpage>&#x02013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.7869/tg.279</pub-id><pub-id pub-id-type="pmid">27522736</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arentz-Hansen</surname><given-names>H.</given-names></name><name><surname>Korner</surname><given-names>R.</given-names></name><name><surname>Molberg</surname><given-names>O.</given-names></name><name><surname>Quarsten</surname><given-names>H.</given-names></name><name><surname>Vader</surname><given-names>W.</given-names></name><name><surname>Kooy</surname><given-names>Y. M.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.</article-title>
<source><italic>J. Exp. Med.</italic></source>
<volume>191</volume>
<fpage>603</fpage>&#x02013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1084/jem.191.4.603</pub-id>
<?supplied-pmid 10684852?><pub-id pub-id-type="pmid">10684852</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethune</surname><given-names>M. T.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Oral enzyme therapy for celiac sprue.</article-title>
<source><italic>Methods Enzymol.</italic></source>
<volume>502</volume>
<fpage>241</fpage>&#x02013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-416039-2.00013-6</pub-id>
<?supplied-pmid 22208988?><pub-id pub-id-type="pmid">22208988</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>J. P.</given-names></name><name><surname>Roovers</surname><given-names>E. A.</given-names></name><name><surname>Drenth</surname><given-names>J. P.</given-names></name><name><surname>Meijer</surname><given-names>J. W.</given-names></name><name><surname>Wahab</surname><given-names>P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Rising incidence of celiac disease in the Netherlands; an analysis of temporal trends from 1995 to 2010.</article-title>
<source><italic>Scand. J. Gastroenterol.</italic></source>
<volume>49</volume>
<fpage>933</fpage>&#x02013;<lpage>941</lpage>. <pub-id pub-id-type="doi">10.3109/00365521.2014.915054</pub-id>
<?supplied-pmid 24873994?><pub-id pub-id-type="pmid">24873994</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calasso</surname><given-names>M.</given-names></name><name><surname>Vincentini</surname><given-names>O.</given-names></name><name><surname>Valitutti</surname><given-names>F.</given-names></name><name><surname>Felli</surname><given-names>C.</given-names></name><name><surname>Gobbetti</surname><given-names>M.</given-names></name><name><surname>Di Cagno</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>The sourdough fermentation may enhance the recovery from intestinal inflammation of coeliac patients at the early stage of the gluten-free diet.</article-title>
<source><italic>Eur. J. Nutr.</italic></source>
<volume>51</volume>
<fpage>507</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-012-0303-y</pub-id>
<?supplied-pmid 22307223?><pub-id pub-id-type="pmid">22307223</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A.</given-names></name><name><surname>Galipeau</surname><given-names>H. J.</given-names></name><name><surname>McCarville</surname><given-names>J. L.</given-names></name><name><surname>Johnston</surname><given-names>C. W.</given-names></name><name><surname>Bernier</surname><given-names>S. P.</given-names></name><name><surname>Russell</surname><given-names>A. K.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>151</volume>
<fpage>670</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2016.06.041</pub-id>
<?supplied-pmid 27373514?><pub-id pub-id-type="pmid">27373514</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A.</given-names></name><name><surname>Herran</surname><given-names>A. R.</given-names></name><name><surname>Nistal</surname><given-names>E.</given-names></name><name><surname>Perez-Andres</surname><given-names>J.</given-names></name><name><surname>Vaquero</surname><given-names>L.</given-names></name><name><surname>Vivas</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.</article-title>
<source><italic>FEMS Microbiol Ecol.</italic></source>
<volume>88</volume>
<fpage>309</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/1574-6941.12295</pub-id>
<?supplied-pmid 24499426?><pub-id pub-id-type="pmid">24499426</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canova</surname><given-names>C.</given-names></name><name><surname>Zabeo</surname><given-names>V.</given-names></name><name><surname>Pitter</surname><given-names>G.</given-names></name><name><surname>Romor</surname><given-names>P.</given-names></name><name><surname>Baldovin</surname><given-names>T.</given-names></name><name><surname>Zanotti</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy.</article-title>
<source><italic>Am. J. Epidemiol.</italic></source>
<volume>180</volume>
<fpage>76</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwu101</pub-id>
<?supplied-pmid 24853109?><pub-id pub-id-type="pmid">24853109</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capozzi</surname><given-names>A.</given-names></name><name><surname>Vincentini</surname><given-names>O.</given-names></name><name><surname>Gizzi</surname><given-names>P.</given-names></name><name><surname>Porzia</surname><given-names>A.</given-names></name><name><surname>Longo</surname><given-names>A.</given-names></name><name><surname>Felli</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Modulatory effect of gliadin peptide 10-mer on epithelial intestinal CACO-2 cell inflammatory response.</article-title>
<source><italic>PLoS One</italic></source>
<volume>8</volume>:<issue>e66561</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0066561</pub-id>
<?supplied-pmid 23823806?><pub-id pub-id-type="pmid">23823806</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caputo</surname><given-names>I.</given-names></name><name><surname>Secondo</surname><given-names>A.</given-names></name><name><surname>Lepretti</surname><given-names>M.</given-names></name><name><surname>Paolella</surname><given-names>G.</given-names></name><name><surname>Auricchio</surname><given-names>S.</given-names></name><name><surname>Barone</surname><given-names>M. V.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2 + mobilization in Caco-2 cells.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e45209</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045209</pub-id>
<?supplied-pmid 23049776?><pub-id pub-id-type="pmid">23049776</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catassi</surname><given-names>C.</given-names></name><name><surname>Fabiani</surname><given-names>E.</given-names></name><name><surname>Ratsch</surname><given-names>I. M.</given-names></name><name><surname>Coppa</surname><given-names>G. V.</given-names></name><name><surname>Giorgi</surname><given-names>P. L.</given-names></name><name><surname>Pierdomenico</surname><given-names>R.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects.</article-title>
<source><italic>Acta Paediatr. Suppl.</italic></source>
<volume>412</volume>
<fpage>29</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.1996.tb14244.x</pub-id>
<?supplied-pmid 8783752?><pub-id pub-id-type="pmid">8783752</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerf-Bensussan</surname><given-names>N.</given-names></name><name><surname>Gaboriau-Routhiau</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>The immune system and the gut microbiota: friends or foes?</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>10</volume>
<fpage>735</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1038/nri2850</pub-id>
<?supplied-pmid 20865020?><pub-id pub-id-type="pmid">20865020</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerf-Bensussan</surname><given-names>N.</given-names></name><name><surname>Matysiak-Budnik</surname><given-names>T.</given-names></name><name><surname>Cellier</surname><given-names>C.</given-names></name><name><surname>Heyman</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Oral proteases: a new approach to managing coeliac disease.</article-title>
<source><italic>Gut</italic></source>
<volume>56</volume>
<fpage>157</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2005.090498</pub-id>
<?supplied-pmid 16950833?><pub-id pub-id-type="pmid">16950833</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chander</surname><given-names>A. M.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Nair</surname><given-names>R. G.</given-names></name><name><surname>Dhawan</surname><given-names>D. K.</given-names></name><name><surname>Kochhar</surname><given-names>R.</given-names></name><name><surname>Mayilraj</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016a</year>). <article-title>Genome sequencing of serinicoccus chungangensis strain CD08_5 isolated from duodenal mucosa of a celiac disease patient.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>4</volume>:<issue>e00043-16</issue>. <pub-id pub-id-type="doi">10.1128/genomeA.00043-16</pub-id>
<?supplied-pmid 26966212?><pub-id pub-id-type="pmid">26966212</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chander</surname><given-names>A. M.</given-names></name><name><surname>Nair</surname><given-names>R. G.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Kochhar</surname><given-names>R.</given-names></name><name><surname>Mayilraj</surname><given-names>S.</given-names></name><name><surname>Dhawan</surname><given-names>D. K.</given-names></name><etal/></person-group> (<year>2016b</year>). <article-title>Genome sequence of kocuria palustris strain CD07_3 isolated from the duodenal mucosa of a celiac disease patient.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>4</volume>:<issue>e00210-16</issue>. <pub-id pub-id-type="doi">10.1128/genomeA.00210-16</pub-id>
<?supplied-pmid 27125478?><pub-id pub-id-type="pmid">27125478</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. S.</given-names></name><name><surname>Christensen</surname><given-names>J. E.</given-names></name><name><surname>Broadbent</surname><given-names>J. R.</given-names></name><name><surname>Steele</surname><given-names>J. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Identification and characterization of <italic>Lactobacillus helveticus</italic> PepO2, an endopeptidase with post-proline specificity.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>69</volume>
<fpage>1276</fpage>&#x02013;<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.69.2.1276-1282.2003</pub-id>
<?supplied-pmid 12571057?><pub-id pub-id-type="pmid">12571057</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Kalliomaki</surname><given-names>M.</given-names></name><name><surname>Heilig</surname><given-names>H. G.</given-names></name><name><surname>Palva</surname><given-names>A.</given-names></name><name><surname>Lahteenoja</surname><given-names>H.</given-names></name><name><surname>de Vos</surname><given-names>W. M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease.</article-title>
<source><italic>BMC Gastroenterol.</italic></source>
<volume>13</volume>:<issue>113</issue>. <pub-id pub-id-type="doi">10.1186/1471-230X-13-113</pub-id>
<?supplied-pmid 23844808?><pub-id pub-id-type="pmid">23844808</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cilleruelo</surname><given-names>M. L.</given-names></name><name><surname>Fernandez-Fernandez</surname><given-names>S.</given-names></name><name><surname>Jimenez-Jimenez</surname><given-names>J.</given-names></name><name><surname>Rayo</surname><given-names>A. I.</given-names></name><name><surname>Larramendi</surname><given-names>C. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence and natural history of celiac disease in a cohort of at-risk children.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>62</volume>
<fpage>739</fpage>&#x02013;<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0000000000001007</pub-id>
<?supplied-pmid 26485606?><pub-id pub-id-type="pmid">26485606</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinova</surname><given-names>J.</given-names></name><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Stepankova</surname><given-names>R.</given-names></name><name><surname>Kofronova</surname><given-names>O.</given-names></name><name><surname>Kverka</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e16169</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016169</pub-id>
<?supplied-pmid 21249146?><pub-id pub-id-type="pmid">21249146</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>M. G.</given-names></name><name><surname>De Virgiliis</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>J. S.</given-names></name><name><surname>Macatagney</surname><given-names>R.</given-names></name><name><surname>Musu</surname><given-names>M. P.</given-names></name><name><surname>Di Pierro</surname><given-names>M. R.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.</article-title>
<source><italic>Gut</italic></source>
<volume>52</volume>
<fpage>218</fpage>&#x02013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1136/gut.52.2.218</pub-id>
<?supplied-pmid 12524403?><pub-id pub-id-type="pmid">12524403</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>M. C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Differences between the fecal microbiota of coeliac infants and healthy controls.</article-title>
<source><italic>Curr. Issues Intest. Microbiol.</italic></source>
<volume>8</volume>
<fpage>9</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">17489434</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>M. C.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Imbalances in faecal and duodenal <italic>Bifidobacterium</italic> species composition in active and non-active coeliac disease.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>8</volume>:<issue>232</issue>. <pub-id pub-id-type="doi">10.1186/1471-2180-8-232</pub-id>
<?supplied-pmid 19102766?><pub-id pub-id-type="pmid">19102766</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>M. C.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease.</article-title>
<source><italic>J. Clin. Pathol.</italic></source>
<volume>62</volume>
<fpage>264</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.2008.061366</pub-id>
<?supplied-pmid 18996905?><pub-id pub-id-type="pmid">18996905</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>L.</given-names></name><name><surname>Munier</surname><given-names>C. M. L.</given-names></name><name><surname>Seddiki</surname><given-names>N.</given-names></name><name><surname>van Bockel</surname><given-names>D.</given-names></name><name><surname>Ontiveros</surname><given-names>N.</given-names></name><name><surname>Hardy</surname><given-names>M. Y.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Circulating gluten-specific FOXP3(+)CD39(+) regulatory T cells have impaired suppressive function in patients with celiac disease.</article-title>
<source><italic>J. Allergy Clin. Immunol.</italic></source>
<volume>140</volume>
<fpage>1592.e8</fpage>&#x02013;<lpage>1603.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.015</pub-id>
<?supplied-pmid 28283419?><pub-id pub-id-type="pmid">28283419</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>V. S.</given-names></name><name><surname>Mattana</surname><given-names>T. C. C.</given-names></name><name><surname>da Silva</surname><given-names>M. E. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Unregulated IL-23/IL-17 immune response in autoimmune diseases.</article-title>
<source><italic>Diabetes. Res. Clin. Pract.</italic></source>
<volume>88</volume>
<fpage>222</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.diabres.2010.03.014</pub-id>
<?supplied-pmid 20392505?><pub-id pub-id-type="pmid">20392505</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Predictable and unpredictable evolution of antibiotic resistance.</article-title>
<source><italic>J. Intern. Med.</italic></source>
<volume>264</volume>
<fpage>4</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2008.01940.x</pub-id>
<?supplied-pmid 18397243?><pub-id pub-id-type="pmid">18397243</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Argenio</surname><given-names>V.</given-names></name><name><surname>Casaburi</surname><given-names>G.</given-names></name><name><surname>Precone</surname><given-names>V.</given-names></name><name><surname>Pagliuca</surname><given-names>C.</given-names></name><name><surname>Colicchio</surname><given-names>R.</given-names></name><name><surname>Sarnataro</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Metagenomics reveals dysbiosis and a potentially pathogenic N. flavescens strain in duodenum of adult celiac patients.</article-title>
<source><italic>Am. J. Gastroenterol.</italic></source>
<volume>111</volume>
<fpage>879</fpage>&#x02013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2016.95</pub-id>
<?supplied-pmid 27045926?><pub-id pub-id-type="pmid">27045926</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Arienzo</surname><given-names>R.</given-names></name><name><surname>Maurano</surname><given-names>F.</given-names></name><name><surname>Luongo</surname><given-names>D.</given-names></name><name><surname>Mazzarella</surname><given-names>G.</given-names></name><name><surname>Stefanile</surname><given-names>R.</given-names></name><name><surname>Troncone</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Adjuvant effect of <italic>Lactobacillus casei</italic> in a mouse model of gluten sensitivity.</article-title>
<source><italic>Immunol. Lett.</italic></source>
<volume>119</volume>
<fpage>78</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2008.04.006</pub-id>
<?supplied-pmid 18547649?><pub-id pub-id-type="pmid">18547649</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Arienzo</surname><given-names>R.</given-names></name><name><surname>Stefanile</surname><given-names>R.</given-names></name><name><surname>Maurano</surname><given-names>F.</given-names></name><name><surname>Mazzarella</surname><given-names>G.</given-names></name><name><surname>Ricca</surname><given-names>E.</given-names></name><name><surname>Troncone</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Immunomodulatory effects of <italic>Lactobacillus casei</italic> administration in a mouse model of gliadin-sensitive enteropathy.</article-title>
<source><italic>Scand. J. Immunol.</italic></source>
<volume>74</volume>
<fpage>335</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3083.2011.02582.x</pub-id>
<?supplied-pmid 21615450?><pub-id pub-id-type="pmid">21615450</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>Fasano</surname><given-names>A.</given-names></name><name><surname>Clemente</surname><given-names>M. G.</given-names></name><name><surname>De Simone</surname><given-names>C.</given-names></name><name><surname>Silano</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1762</volume>
<fpage>80</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2005.09.008</pub-id>
<?supplied-pmid 16311022?><pub-id pub-id-type="pmid">16311022</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Meij</surname><given-names>T. G.</given-names></name><name><surname>Budding</surname><given-names>A. E.</given-names></name><name><surname>Grasman</surname><given-names>M. E.</given-names></name><name><surname>Kneepkens</surname><given-names>C. M.</given-names></name><name><surname>Savelkoul</surname><given-names>P. H.</given-names></name><name><surname>Mearin</surname><given-names>M. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease.</article-title>
<source><italic>Scand. J. Gastroenterol.</italic></source>
<volume>48</volume>
<fpage>530</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.3109/00365521.2013.775666</pub-id>
<?supplied-pmid 23534388?><pub-id pub-id-type="pmid">23534388</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Cinova</surname><given-names>J.</given-names></name><name><surname>Stepankova</surname><given-names>R.</given-names></name><name><surname>Tuckova</surname><given-names>L.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Pivotal advance: bifidobacteria and gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.</article-title>
<source><italic>J. Leukoc. Biol.</italic></source>
<volume>87</volume>
<fpage>765</fpage>&#x02013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0709471</pub-id>
<?supplied-pmid 20007908?><pub-id pub-id-type="pmid">20007908</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Silvestri</surname><given-names>A.</given-names></name><name><surname>Capittini</surname><given-names>C.</given-names></name><name><surname>Poddighe</surname><given-names>D.</given-names></name><name><surname>Valsecchi</surname><given-names>C.</given-names></name><name><surname>Marseglia</surname><given-names>G.</given-names></name><name><surname>Tagliacarne</surname><given-names>S. C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ &#x003b2; chains.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>83</volume>
<fpage>564</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2017.307</pub-id>
<?supplied-pmid 29244800?><pub-id pub-id-type="pmid">29244800</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vincenzi</surname><given-names>M.</given-names></name><name><surname>Vincentini</surname><given-names>O.</given-names></name><name><surname>Di Nardo</surname><given-names>G.</given-names></name><name><surname>Boirivant</surname><given-names>M.</given-names></name><name><surname>Gazza</surname><given-names>L.</given-names></name><name><surname>Pogna</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins.</article-title>
<source><italic>Eur. J. Nutr.</italic></source>
<volume>49</volume>
<fpage>251</fpage>&#x02013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-009-0080-4</pub-id>
<?supplied-pmid 19894071?><pub-id pub-id-type="pmid">19894071</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewar</surname><given-names>D. H.</given-names></name><name><surname>Amato</surname><given-names>M.</given-names></name><name><surname>Ellis</surname><given-names>H. J.</given-names></name><name><surname>Pollock</surname><given-names>E. L.</given-names></name><name><surname>Gonzalez-Cinca</surname><given-names>N.</given-names></name><name><surname>Wieser</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease.</article-title>
<source><italic>Eur. J. Gastroenterol. Hepatol.</italic></source>
<volume>18</volume>
<fpage>483</fpage>&#x02013;<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1097/00042737-200605000-00005</pub-id><pub-id pub-id-type="pmid">16607142</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>Barbato</surname><given-names>M.</given-names></name><name><surname>Di Camillo</surname><given-names>C.</given-names></name><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Giuliani</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>51</volume>
<fpage>777</fpage>&#x02013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e3181f22ba4</pub-id>
<?supplied-pmid 20975578?><pub-id pub-id-type="pmid">20975578</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Auricchio</surname><given-names>S.</given-names></name><name><surname>Greco</surname><given-names>L.</given-names></name><name><surname>Clarke</surname><given-names>C.</given-names></name><name><surname>De Vincenzi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>70</volume>
<fpage>1088</fpage>&#x02013;<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.70.2.1088-1096.2004</pub-id>
<?supplied-pmid 14766592?><pub-id pub-id-type="pmid">14766592</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>De Pasquale</surname><given-names>I.</given-names></name><name><surname>Ndagijimana</surname><given-names>M.</given-names></name><name><surname>Vernocchi</surname><given-names>P.</given-names></name><name><surname>Ricciuti</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>11</volume>:<issue>219</issue>. <pub-id pub-id-type="doi">10.1186/1471-2180-11-219</pub-id>
<?supplied-pmid 21970810?><pub-id pub-id-type="pmid">21970810</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Cassone</surname><given-names>A.</given-names></name><name><surname>Giuliani</surname><given-names>G.</given-names></name><name><surname>Benedusi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Use of selected sourdough strains of <italic>Lactobacillus</italic> for removing gluten and enhancing the nutritional properties of gluten-free bread.</article-title>
<source><italic>J. Food Prot.</italic></source>
<volume>71</volume>
<fpage>1491</fpage>&#x02013;<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.4315/0362-028X-71.7.1491</pub-id>
<?supplied-pmid 18680953?><pub-id pub-id-type="pmid">18680953</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>Gagliardi</surname><given-names>F.</given-names></name><name><surname>Ricciuti</surname><given-names>P.</given-names></name><name><surname>Ndagijimana</surname><given-names>M.</given-names></name><name><surname>Francavilla</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>75</volume>
<fpage>3963</fpage>&#x02013;<lpage>3971</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02793-08</pub-id>
<?supplied-pmid 19376912?><pub-id pub-id-type="pmid">19376912</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>S.</given-names></name><name><surname>El Asmar</surname><given-names>R.</given-names></name><name><surname>Di Pierro</surname><given-names>M.</given-names></name><name><surname>Grazia Clemente</surname><given-names>M.</given-names></name><name><surname>Tripathi</surname><given-names>A.</given-names></name><name><surname>Sapone</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.</article-title>
<source><italic>Scand. J. Gastroenterol.</italic></source>
<volume>41</volume>
<fpage>408</fpage>&#x02013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1080/00365520500235334</pub-id>
<?supplied-pmid 16635908?><pub-id pub-id-type="pmid">16635908</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duar</surname><given-names>R. M.</given-names></name><name><surname>Clark</surname><given-names>K.</given-names></name><name><surname>Patil</surname><given-names>P. B.</given-names></name><name><surname>Hernandez</surname><given-names>C.</given-names></name><name><surname>Bruning</surname><given-names>S.</given-names></name><name><surname>Burkey</surname><given-names>T. E.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>118</volume>
<fpage>515</fpage>&#x02013;<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1111/jam.12687</pub-id>
<?supplied-pmid 25376327?><pub-id pub-id-type="pmid">25376327</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duar</surname><given-names>R. M.</given-names></name><name><surname>Clark</surname><given-names>K. J.</given-names></name><name><surname>Patil</surname><given-names>P. B.</given-names></name><name><surname>Hernandez</surname><given-names>C.</given-names></name><name><surname>Bruning</surname><given-names>S.</given-names></name><name><surname>Burkey</surname><given-names>T. E.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>118</volume>
<fpage>515</fpage>&#x02013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1111/jam.12687</pub-id>
<?supplied-pmid 25376327?><pub-id pub-id-type="pmid">25376327</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duenas</surname><given-names>M.</given-names></name><name><surname>Munoz-Gonzalez</surname><given-names>I.</given-names></name><name><surname>Cueva</surname><given-names>C.</given-names></name><name><surname>Jimenez-Giron</surname><given-names>A.</given-names></name><name><surname>Sanchez-Patan</surname><given-names>F.</given-names></name><name><surname>Santos-Buelga</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A survey of modulation of gut microbiota by dietary polyphenols.</article-title>
<source><italic>Biomed. Res. Int.</italic></source>
<volume>2015</volume>:<issue>850902</issue>. <pub-id pub-id-type="doi">10.1155/2015/850902</pub-id>
<?supplied-pmid 25793210?><pub-id pub-id-type="pmid">25793210</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duranti</surname><given-names>S.</given-names></name><name><surname>Lugli</surname><given-names>G. A.</given-names></name><name><surname>Mancabelli</surname><given-names>L.</given-names></name><name><surname>Turroni</surname><given-names>F.</given-names></name><name><surname>Milani</surname><given-names>C.</given-names></name><name><surname>Mangifesta</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Prevalence of antibiotic resistance genes among human gut-derived bifidobacteria.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>83</volume>:<issue>e02894-16</issue>. <pub-id pub-id-type="doi">10.1128/AEM.02894-16</pub-id>
<?supplied-pmid 27864179?><pub-id pub-id-type="pmid">27864179</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egervarn</surname><given-names>M.</given-names></name><name><surname>Lindmark</surname><given-names>H.</given-names></name><name><surname>Olsson</surname><given-names>J.</given-names></name><name><surname>Roos</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Transferability of a tetracycline resistance gene from probiotic <italic>Lactobacillus reuteri</italic> to bacteria in the gastrointestinal tract of humans.</article-title>
<source><italic>Antonie Van Leeuwenhoek</italic></source>
<volume>97</volume>
<fpage>189</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1007/s10482-009-9401-0</pub-id>
<?supplied-pmid 19997864?><pub-id pub-id-type="pmid">19997864</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enroth</surname><given-names>S.</given-names></name><name><surname>Dahlbom</surname><given-names>I.</given-names></name><name><surname>Hansson</surname><given-names>T.</given-names></name><name><surname>Johansson</surname><given-names>A.</given-names></name><name><surname>Gyllensten</surname><given-names>U.</given-names></name></person-group> (<year>2013</year>). <article-title>Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden population health study.</article-title>
<source><italic>Int. J. Circumpolar Health</italic></source>
<volume>5</volume>:<issue>72</issue>. <pub-id pub-id-type="doi">10.3402/ijch.v72i0.21403</pub-id>
<?supplied-pmid 23986895?><pub-id pub-id-type="pmid">23986895</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ercolini</surname><given-names>D.</given-names></name><name><surname>Francavilla</surname><given-names>R.</given-names></name><name><surname>Vannini</surname><given-names>L.</given-names></name><name><surname>De Filippis</surname><given-names>F.</given-names></name><name><surname>Capriati</surname><given-names>T.</given-names></name><name><surname>Di Cagno</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>From an imbalance to a new imbalance: italian-style gluten-free diet alters the salivary microbiota and metabolome of African celiac children.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>5</volume>:<issue>18571</issue>. <pub-id pub-id-type="doi">10.1038/srep18571</pub-id>
<?supplied-pmid 26681599?><pub-id pub-id-type="pmid">26681599</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A.</given-names></name><name><surname>Not</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Uzzau</surname><given-names>S.</given-names></name><name><surname>Berti</surname><given-names>I.</given-names></name><name><surname>Tommasini</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.</article-title>
<source><italic>Lancet</italic></source>
<volume>355</volume>
<fpage>1518</fpage>&#x02013;<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)02169-3</pub-id>
<?supplied-pmid 10801176?><pub-id pub-id-type="pmid">10801176</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Feo</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Blumenkranz</surname><given-names>G.</given-names></name><name><surname>Dewhirst</surname><given-names>F. E.</given-names></name><name><surname>Schuppan</surname><given-names>D.</given-names></name><name><surname>Oppenheim</surname><given-names>F. G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.</article-title>
<source><italic>Clin. Microbiol. Infect.</italic></source>
<volume>19</volume>
<fpage>E386</fpage>&#x02013;<lpage>E394</lpage>. <pub-id pub-id-type="doi">10.1111/1469-0691.12249</pub-id>
<?supplied-pmid 23714165?><pub-id pub-id-type="pmid">23714165</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francavilla</surname><given-names>R.</given-names></name><name><surname>Ercolini</surname><given-names>D.</given-names></name><name><surname>Piccolo</surname><given-names>M.</given-names></name><name><surname>Vannini</surname><given-names>L.</given-names></name><name><surname>Siragusa</surname><given-names>S.</given-names></name><name><surname>De Filippis</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Salivary microbiota and metabolome associated with celiac disease.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>80</volume>
<fpage>3416</fpage>&#x02013;<lpage>3425</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.00362-14</pub-id>
<?supplied-pmid 24657864?><pub-id pub-id-type="pmid">24657864</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzosa</surname><given-names>E. A.</given-names></name><name><surname>Morgan</surname><given-names>X. C.</given-names></name><name><surname>Segata</surname><given-names>N.</given-names></name><name><surname>Waldron</surname><given-names>L.</given-names></name><name><surname>Reyes</surname><given-names>J.</given-names></name><name><surname>Earl</surname><given-names>A. M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Relating the metatranscriptome and metagenome of the human gut.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>111</volume>
<fpage>E2329</fpage>&#x02013;<lpage>E2338</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1319284111</pub-id>
<?supplied-pmid 24843156?><pub-id pub-id-type="pmid">24843156</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furusawa</surname><given-names>Y.</given-names></name><name><surname>Obata</surname><given-names>Y.</given-names></name><name><surname>Fukuda</surname><given-names>S.</given-names></name><name><surname>Endo</surname><given-names>T. A.</given-names></name><name><surname>Nakato</surname><given-names>G.</given-names></name><name><surname>Takahashi</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.</article-title>
<source><italic>Nature</italic></source>
<volume>504</volume>
<fpage>446</fpage>&#x02013;<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1038/nature12721</pub-id>
<?supplied-pmid 24226770?><pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gass</surname><given-names>J.</given-names></name><name><surname>Bethune</surname><given-names>M. T.</given-names></name><name><surname>Siegel</surname><given-names>M.</given-names></name><name><surname>Spencer</surname><given-names>A.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>133</volume>
<fpage>472</fpage>&#x02013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.05.028</pub-id>
<?supplied-pmid 17681168?><pub-id pub-id-type="pmid">17681168</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerez</surname><given-names>C. L.</given-names></name><name><surname>Font de Valdez</surname><given-names>G.</given-names></name><name><surname>Rollan</surname><given-names>G. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Functionality of lactic acid bacteria peptidase activities in the hydrolysis of gliadin-like fragments.</article-title>
<source><italic>Lett. Appl. Microbiol.</italic></source>
<volume>47</volume>
<fpage>427</fpage>&#x02013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.2008.02448.x</pub-id>
<?supplied-pmid 19146533?><pub-id pub-id-type="pmid">19146533</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>T. S.</given-names></name><name><surname>Gupta</surname><given-names>S. S.</given-names></name><name><surname>Bhattacharya</surname><given-names>T.</given-names></name><name><surname>Yadav</surname><given-names>D.</given-names></name><name><surname>Barik</surname><given-names>A.</given-names></name><name><surname>Chowdhury</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Gut microbiomes of Indian children of varying nutritional status.</article-title>
<source><italic>PLoS One</italic></source>
<volume>9</volume>:<issue>e95547</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0095547</pub-id>
<?supplied-pmid 24763225?><pub-id pub-id-type="pmid">24763225</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacomin</surname><given-names>P.</given-names></name><name><surname>Zakrzewski</surname><given-names>M.</given-names></name><name><surname>Croese</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>Sotillo</surname><given-names>J.</given-names></name><name><surname>McCann</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Experimental hookworm infection and escalating gluten challenges are associated with increased microbial richness in celiac subjects.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>5</volume>:<issue>13797</issue>. <pub-id pub-id-type="doi">10.1038/srep13797</pub-id>
<?supplied-pmid 26381211?><pub-id pub-id-type="pmid">26381211</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gianfrani</surname><given-names>C.</given-names></name><name><surname>Auricchio</surname><given-names>S.</given-names></name><name><surname>Troncone</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Adaptive and innate immune responses in celiac disease.</article-title>
<source><italic>Immunol. Lett.</italic></source>
<volume>99</volume>
<fpage>141</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2005.02.017</pub-id>
<?supplied-pmid 15876458?><pub-id pub-id-type="pmid">15876458</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordani</surname><given-names>L.</given-names></name><name><surname>Del Pinto</surname><given-names>T.</given-names></name><name><surname>Vincentini</surname><given-names>O.</given-names></name><name><surname>Felli</surname><given-names>C.</given-names></name><name><surname>Silano</surname><given-names>M.</given-names></name><name><surname>Viora</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Two wheat decapeptides prevent gliadin-dependent maturation of human dendritic cells.</article-title>
<source><italic>Exp. Cell Res.</italic></source>
<volume>321</volume>
<fpage>248</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2013.11.008</pub-id>
<?supplied-pmid 24262078?><pub-id pub-id-type="pmid">24262078</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giron Fernandez-Crehuet</surname><given-names>F.</given-names></name><name><surname>Tapia-Paniagua</surname><given-names>S.</given-names></name><name><surname>Morinigo Gutierrez</surname><given-names>M. A.</given-names></name><name><surname>Navas-Lopez</surname><given-names>V. M.</given-names></name><name><surname>Juliana Serrano</surname><given-names>M.</given-names></name><name><surname>Blasco-Alonso</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The duodenal microbiota composition in children with active coeliac disease is influenced for the degree of enteropathy.</article-title>
<source><italic>An Pediatr.</italic></source>
<volume>84</volume>
<fpage>224</fpage>&#x02013;<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1016/j.anpedi.2015.06.014</pub-id>
<?supplied-pmid 26602204?><pub-id pub-id-type="pmid">26602204</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobbetti</surname><given-names>M.</given-names></name><name><surname>Giuseppe Rizzello</surname><given-names>C.</given-names></name><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Sourdough lactobacilli and celiac disease.</article-title>
<source><italic>Food Microbiol.</italic></source>
<volume>24</volume>
<fpage>187</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2006.07.014</pub-id>
<?supplied-pmid 17008163?><pub-id pub-id-type="pmid">17008163</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golfetto</surname><given-names>L.</given-names></name><name><surname>de Senna</surname><given-names>F. D.</given-names></name><name><surname>Hermes</surname><given-names>J.</given-names></name><name><surname>Beserra</surname><given-names>B. T.</given-names></name><name><surname>Franca Fda</surname><given-names>S.</given-names></name><name><surname>Martinello</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet.</article-title>
<source><italic>Arq. Gastroenterol.</italic></source>
<volume>51</volume>
<fpage>139</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1590/S0004-28032014000200013</pub-id>
<?supplied-pmid 25003267?><pub-id pub-id-type="pmid">25003267</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorham</surname><given-names>J. B.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Williams</surname><given-names>B. A.</given-names></name><name><surname>Grant</surname><given-names>L. J.</given-names></name><name><surname>McSweeney</surname><given-names>C. S.</given-names></name><name><surname>Gidley</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Addition of arabinoxylan and mixed linkage glucans in porcine diets affects the large intestinal bacterial populations.</article-title>
<source><italic>Eur. J. Nutr.</italic></source>
<volume>56</volume>
<fpage>2193</fpage>&#x02013;<lpage>2206</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-016-1263-4</pub-id>
<?supplied-pmid 27401929?><pub-id pub-id-type="pmid">27401929</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>L.</given-names></name><name><surname>Gobbetti</surname><given-names>M.</given-names></name><name><surname>Auricchio</surname><given-names>R.</given-names></name><name><surname>Di Mase</surname><given-names>R.</given-names></name><name><surname>Landolfo</surname><given-names>F.</given-names></name><name><surname>Paparo</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing.</article-title>
<source><italic>Clin. Gastroenterol. Hepatol.</italic></source>
<volume>9</volume>
<fpage>24</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.cgh.2010.09.025</pub-id>
<?supplied-pmid 20951830?><pub-id pub-id-type="pmid">20951830</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>F.</given-names></name><name><surname>Perdigon</surname><given-names>G.</given-names></name><name><surname>Corthier</surname><given-names>G.</given-names></name><name><surname>Salminen</surname><given-names>S.</given-names></name><name><surname>Koletzko</surname><given-names>B.</given-names></name><name><surname>Morelli</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Should yoghurt cultures be considered probiotic?</article-title>
<source><italic>Br. J. Nutr.</italic></source>
<volume>93</volume>
<fpage>783</fpage>&#x02013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1079/BJN20051428</pub-id><pub-id pub-id-type="pmid">16022746</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Achury</surname><given-names>J.</given-names></name><name><surname>Zhernakova</surname><given-names>A.</given-names></name><name><surname>Pulit</surname><given-names>S. L.</given-names></name><name><surname>Trynka</surname><given-names>G.</given-names></name><name><surname>Hunt</surname><given-names>K. A.</given-names></name><name><surname>Romanos</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease.</article-title>
<source><italic>Nat. Genet.</italic></source>
<volume>47</volume>
<fpage>577</fpage>&#x02013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3268</pub-id>
<?supplied-pmid 25894500?><pub-id pub-id-type="pmid">25894500</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausch</surname><given-names>F.</given-names></name><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Santiago</surname><given-names>N. A.</given-names></name><name><surname>Gray</surname><given-names>G. M.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2002</year>). <article-title>Intestinal digestive resistance of immunodominant gliadin peptides.</article-title>
<source><italic>Am. J. Physiol. Gastrointest. Liver Physiol.</italic></source>
<volume>283</volume>
<fpage>G996</fpage>&#x02013;<lpage>G1003</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00136.2002</pub-id>
<?supplied-pmid 12223360?><pub-id pub-id-type="pmid">12223360</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmerhorst</surname><given-names>E. J.</given-names></name><name><surname>Zamakhchari</surname><given-names>M.</given-names></name><name><surname>Schuppan</surname><given-names>D.</given-names></name><name><surname>Oppenheim</surname><given-names>F. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.</article-title>
<source><italic>PLoS One</italic></source>
<volume>5</volume>:<issue>e13264</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0013264</pub-id>
<?supplied-pmid 20948997?><pub-id pub-id-type="pmid">20948997</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herran</surname><given-names>A. R.</given-names></name><name><surname>Perez-Andres</surname><given-names>J.</given-names></name><name><surname>Caminero</surname><given-names>A.</given-names></name><name><surname>Nistal</surname><given-names>E.</given-names></name><name><surname>Vivas</surname><given-names>S.</given-names></name><name><surname>Ruiz de Morales</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients.</article-title>
<source><italic>Res. Microbiol.</italic></source>
<volume>168</volume>
<fpage>673</fpage>&#x02013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.resmic.2017.04.008</pub-id>
<?supplied-pmid 28526528?><pub-id pub-id-type="pmid">28526528</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Littman</surname><given-names>D. R.</given-names></name></person-group> (<year>2012</year>). <article-title>The microbiome in infectious disease and inflammation.</article-title>
<source><italic>Annu. Rev. Immunol.</italic></source>
<volume>30</volume>
<fpage>759</fpage>&#x02013;<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074937</pub-id>
<?supplied-pmid 22224764?><pub-id pub-id-type="pmid">22224764</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huibregtse</surname><given-names>I. L.</given-names></name><name><surname>Marietta</surname><given-names>E. V.</given-names></name><name><surname>Rashtak</surname><given-names>S.</given-names></name><name><surname>Koning</surname><given-names>F.</given-names></name><name><surname>Rottiers</surname><given-names>P.</given-names></name><name><surname>David</surname><given-names>C. S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Induction of antigen-specific tolerance by oral administration of <italic>Lactococcus lactis</italic> delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.</article-title>
<source><italic>J. Immunol.</italic></source>
<volume>183</volume>
<fpage>2390</fpage>&#x02013;<lpage>2396</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0802891</pub-id>
<?supplied-pmid 19635921?><pub-id pub-id-type="pmid">19635921</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iacomino</surname><given-names>G.</given-names></name><name><surname>Fierro</surname><given-names>O.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>S.</given-names></name><name><surname>Picariello</surname><given-names>G.</given-names></name><name><surname>Ferranti</surname><given-names>P.</given-names></name><name><surname>Liguori</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Structural analysis and Caco-2 cell permeability of the celiac-toxic A-gliadin peptide 31-55.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>61</volume>
<fpage>1088</fpage>&#x02013;<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1021/jf3045523</pub-id>
<?supplied-pmid 23298305?><pub-id pub-id-type="pmid">23298305</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiminez</surname><given-names>J. A.</given-names></name><name><surname>Uwiera</surname><given-names>T. C.</given-names></name><name><surname>Abbott</surname><given-names>D. W.</given-names></name><name><surname>Uwiera</surname><given-names>R. R.</given-names></name><name><surname>Inglis</surname><given-names>G. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with <italic>Citrobacter rodentium</italic>. mSphere</article-title>
<volume>2</volume>:<issue>e00243-17</issue>.</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>D. G.</given-names></name><name><surname>Corr</surname><given-names>S. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Toll-like receptor signalling and the control of intestinal barrier function.</article-title>
<source><italic>Methods Mol. Biol.</italic></source>
<volume>1390</volume>
<fpage>287</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-3335-8-18</pub-id>
<?supplied-pmid 26803636?><pub-id pub-id-type="pmid">26803636</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalliomaki</surname><given-names>M.</given-names></name><name><surname>Satokari</surname><given-names>R.</given-names></name><name><surname>Lahteenoja</surname><given-names>H.</given-names></name><name><surname>Vahamiko</surname><given-names>S.</given-names></name><name><surname>Gronlund</surname><given-names>J.</given-names></name><name><surname>Routi</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Expression of microbiota, toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>54</volume>
<fpage>727</fpage>&#x02013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e318241cfa8</pub-id>
<?supplied-pmid 22134550?><pub-id pub-id-type="pmid">22134550</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Sarkar</surname><given-names>N.</given-names></name><name><surname>Bhatnagar</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Rapthap</surname><given-names>C.</given-names></name><name><surname>Bhan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes.</article-title>
<source><italic>Hum. Immunol.</italic></source>
<volume>63</volume>
<fpage>677</fpage>&#x02013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1016/S0198-8859(02)00413-5</pub-id><pub-id pub-id-type="pmid">12121676</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieliszek</surname><given-names>M.</given-names></name><name><surname>Misiewicz</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbial transglutaminase and its application in the food industry. A review.</article-title>
<source><italic>Folia Microbiol.</italic></source>
<volume>59</volume>
<fpage>241</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s12223-013-0287-x</pub-id>
<?supplied-pmid 24198201?><pub-id pub-id-type="pmid">24198201</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klemenak</surname><given-names>M.</given-names></name><name><surname>Dolinsek</surname><given-names>J.</given-names></name><name><surname>Langerholc</surname><given-names>T.</given-names></name><name><surname>Di Gioia</surname><given-names>D.</given-names></name><name><surname>Micetic-Turk</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Administration of <italic>Bifidobacterium breve</italic> decreases the production of TNF-alpha in children with celiac disease.</article-title>
<source><italic>Dig. Dis. Sci.</italic></source>
<volume>60</volume>
<fpage>3386</fpage>&#x02013;<lpage>3392</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-015-3769-7</pub-id>
<?supplied-pmid 26134988?><pub-id pub-id-type="pmid">26134988</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Sharma</surname><given-names>G.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Tandon</surname><given-names>N.</given-names></name><name><surname>Bhatnagar</surname><given-names>S.</given-names></name><name><surname>Mehra</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Major histocompatibility complex class I chain related gene-A microsatellite polymorphism shows secondary association with type 1 diabetes and celiac disease in North Indians.</article-title>
<source><italic>Tissue Antigens</italic></source>
<volume>80</volume>
<fpage>356</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0039.2012.01931.x</pub-id>
<?supplied-pmid 22835336?><pub-id pub-id-type="pmid">22835336</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Goswami</surname><given-names>R.</given-names></name><name><surname>Agarwal</surname><given-names>S.</given-names></name><name><surname>Israni</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>S. K.</given-names></name><name><surname>Rani</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.</article-title>
<source><italic>Tissue Antigens</italic></source>
<volume>69</volume>
<fpage>557</fpage>&#x02013;<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0039.2007.00817.x</pub-id>
<?supplied-pmid 17498265?><pub-id pub-id-type="pmid">17498265</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laass</surname><given-names>M. W.</given-names></name><name><surname>Schmitz</surname><given-names>R.</given-names></name><name><surname>Uhlig</surname><given-names>H. H.</given-names></name><name><surname>Zimmer</surname><given-names>K. P.</given-names></name><name><surname>Thamm</surname><given-names>M.</given-names></name><name><surname>Koletzko</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The prevalence of celiac disease in children and adolescents in Germany.</article-title>
<source><italic>Dtsch. Arztebl. Int.</italic></source>
<volume>112</volume>
<fpage>553</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.3238/arztebl.2015.0553</pub-id>
<?supplied-pmid 26356552?><pub-id pub-id-type="pmid">26356552</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahdeaho</surname><given-names>M. L.</given-names></name><name><surname>Kaukinen</surname><given-names>K.</given-names></name><name><surname>Laurila</surname><given-names>K.</given-names></name><name><surname>Vuotikka</surname><given-names>P.</given-names></name><name><surname>Koivurova</surname><given-names>O. P.</given-names></name><name><surname>Karja-Lahdensuu</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>146</volume>
<fpage>1649</fpage>&#x02013;<lpage>1658</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.031</pub-id>
<?supplied-pmid 24583059?><pub-id pub-id-type="pmid">24583059</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laparra</surname><given-names>J. M.</given-names></name><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Gallina</surname><given-names>O.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Bifidobacterium longum</italic> CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e30744</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0030744</pub-id>
<?supplied-pmid 22348021?><pub-id pub-id-type="pmid">22348021</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laparra</surname><given-names>J. M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Bifidobacteria</italic> inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion.</article-title>
<source><italic>J. Cell. Biochem.</italic></source>
<volume>109</volume>
<fpage>801</fpage>&#x02013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.22459</pub-id>
<?supplied-pmid 20052669?><pub-id pub-id-type="pmid">20052669</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehtim&#x000e4;ki</surname><given-names>S.</given-names></name><name><surname>Lahesmaa</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulatory T cells control immune responses through their non-redundant tissue specific features.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>4</volume>:<issue>294</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00294</pub-id>
<?supplied-pmid 24069022?><pub-id pub-id-type="pmid">24069022</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A.</given-names></name><name><surname>Jeremias</surname><given-names>P.</given-names></name><name><surname>Matthias</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>The world incidence and prevalence of autoimmune diseases is increasing.</article-title>
<source><italic>Int. J. Celiac. Dis.</italic></source>
<volume>3</volume>
<fpage>151</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.12691/ijcd-3-4-8</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A.</given-names></name><name><surname>Matthias</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.</article-title>
<source><italic>Nutr. Rev.</italic></source>
<volume>73</volume>
<fpage>544</fpage>&#x02013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuv011</pub-id>
<?supplied-pmid 26084478?><pub-id pub-id-type="pmid">26084478</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A.</given-names></name><name><surname>Matthias</surname><given-names>T.</given-names></name><name><surname>Aminov</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Potential effects of horizontal gene exchange in the human gut.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>8</volume>:<issue>1630</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01630</pub-id>
<?supplied-pmid 29230215?><pub-id pub-id-type="pmid">29230215</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.</article-title>
<source><italic>Clin. Immunol.</italic></source>
<volume>126</volume>
<fpage>67</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2007.08.017</pub-id>
<?supplied-pmid 17964857?><pub-id pub-id-type="pmid">17964857</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>H. S.</given-names></name><name><surname>Aronsson</surname><given-names>C. A.</given-names></name><name><surname>Hagopian</surname><given-names>W. A.</given-names></name><name><surname>Koletzko</surname><given-names>S.</given-names></name><name><surname>Rewers</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Risk of pediatric celiac disease according to HLA haplotype and country.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>371</volume>
<fpage>42</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1313977</pub-id>
<?supplied-pmid 24988556?><pub-id pub-id-type="pmid">24988556</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo Pisarello</surname><given-names>M. J.</given-names></name><name><surname>Vintini</surname><given-names>E. O.</given-names></name><name><surname>Gonzalez</surname><given-names>S. N.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Medina</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Decrease in lactobacilli in the intestinal microbiota of celiac children with a gluten-free diet, and selection of potentially probiotic strains.</article-title>
<source><italic>Can. J. Microbiol.</italic></source>
<volume>61</volume>
<fpage>32</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1139/cjm-2014-0472</pub-id>
<?supplied-pmid 25438612?><pub-id pub-id-type="pmid">25438612</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamone</surname><given-names>G.</given-names></name><name><surname>Camarca</surname><given-names>A.</given-names></name><name><surname>Fierro</surname><given-names>O.</given-names></name><name><surname>Sidney</surname><given-names>J.</given-names></name><name><surname>Mazzarella</surname><given-names>G.</given-names></name><name><surname>Addeo</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>61</volume>
<fpage>747</fpage>&#x02013;<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1021/jf3040435</pub-id>
<?supplied-pmid 23244345?><pub-id pub-id-type="pmid">23244345</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardini</surname><given-names>H. E.</given-names></name><name><surname>Westgate</surname><given-names>P.</given-names></name><name><surname>Grigorian</surname><given-names>A. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Racial differences in the prevalence of celiac disease in the US population: national health and nutrition examination survey (NHANES) 2009-2012.</article-title>
<source><italic>Dig. Dis. Sci.</italic></source>
<volume>60</volume>
<fpage>1738</fpage>&#x02013;<lpage>1742</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-014-3514-7</pub-id>
<?supplied-pmid 25577269?><pub-id pub-id-type="pmid">25577269</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariadason</surname><given-names>J. M.</given-names></name><name><surname>Barkla</surname><given-names>D. H.</given-names></name><name><surname>Gibson</surname><given-names>P. R.</given-names></name></person-group> (<year>1997</year>). <article-title>Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model.</article-title>
<source><italic>Am. J. Physiol.</italic></source>
<volume>272</volume>
<fpage>G705</fpage>&#x02013;<lpage>G712</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.1997.272.4.G705</pub-id>
<?supplied-pmid 9142899?><pub-id pub-id-type="pmid">9142899</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>T.</given-names></name><name><surname>Molberg</surname><given-names>O.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Gray</surname><given-names>G. M.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name><name><surname>Sollid</surname><given-names>L. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization.</article-title>
<source><italic>J. Pharmacol. Exp. Ther.</italic></source>
<volume>312</volume>
<fpage>19</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.073312</pub-id>
<?supplied-pmid 15358813?><pub-id pub-id-type="pmid">15358813</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthias</surname><given-names>T.</given-names></name><name><surname>Jeremias</surname><given-names>P.</given-names></name><name><surname>Neidhofer</surname><given-names>S.</given-names></name><name><surname>Lerner</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients.</article-title>
<source><italic>Autoimmun. Rev.</italic></source>
<volume>15</volume>
<fpage>1111</fpage>&#x02013;<lpage>1119</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2016.09.011</pub-id>
<?supplied-pmid 27640315?><pub-id pub-id-type="pmid">27640315</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehra</surname><given-names>N. K.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Kanga</surname><given-names>U.</given-names></name><name><surname>Tandon</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population.</article-title>
<source><italic>Indian J. Med. Res.</italic></source>
<volume>125</volume>
<fpage>321</fpage>&#x02013;<lpage>344</lpage>.<pub-id pub-id-type="pmid">17496359</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menard</surname><given-names>S.</given-names></name><name><surname>Cerf-Bensussan</surname><given-names>N.</given-names></name><name><surname>Heyman</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Multiple facets of intestinal permeability and epithelial handling of dietary antigens.</article-title>
<source><italic>Mucosal Immunol.</italic></source>
<volume>3</volume>
<fpage>247</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2010.5</pub-id>
<?supplied-pmid 20404811?><pub-id pub-id-type="pmid">20404811</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meresse</surname><given-names>B.</given-names></name><name><surname>Ripoche</surname><given-names>J.</given-names></name><name><surname>Heyman</surname><given-names>M.</given-names></name><name><surname>Cerf-Bensussan</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.</article-title>
<source><italic>Mucosal Immunol.</italic></source>
<volume>2</volume>
<fpage>8</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2008.75</pub-id>
<?supplied-pmid 19079330?><pub-id pub-id-type="pmid">19079330</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Prakash</surname><given-names>S.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Sreenivas</surname><given-names>V.</given-names></name><name><surname>Ahuja</surname><given-names>V.</given-names></name><name><surname>Gupta</surname><given-names>S. D.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Prevalence of celiac disease among first-degree relatives of indian celiac disease patients.</article-title>
<source><italic>Dig. Liver Dis.</italic></source>
<volume>48</volume>
<fpage>255</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.dld.2015.11.007</pub-id>
<?supplied-pmid 26691992?><pub-id pub-id-type="pmid">26691992</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitea</surname><given-names>C.</given-names></name><name><surname>Havenaar</surname><given-names>R.</given-names></name><name><surname>Drijfhout</surname><given-names>J. W.</given-names></name><name><surname>Edens</surname><given-names>L.</given-names></name><name><surname>Dekking</surname><given-names>L.</given-names></name><name><surname>Koning</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.</article-title>
<source><italic>Gut</italic></source>
<volume>57</volume>
<fpage>25</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2006.111609</pub-id>
<?supplied-pmid 17494108?><pub-id pub-id-type="pmid">17494108</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molberg</surname><given-names>O.</given-names></name><name><surname>Solheim Flaete</surname><given-names>N.</given-names></name><name><surname>Jensen</surname><given-names>T.</given-names></name><name><surname>Lundin</surname><given-names>K. E.</given-names></name><name><surname>Arentz-Hansen</surname><given-names>H.</given-names></name><name><surname>Anderson</surname><given-names>O. D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>125</volume>
<fpage>337</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/S0016-5085(03)00890-4</pub-id>
<?supplied-pmid 12891534?><pub-id pub-id-type="pmid">12891534</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustalahti</surname><given-names>K.</given-names></name><name><surname>Catassi</surname><given-names>C.</given-names></name><name><surname>Reunanen</surname><given-names>A.</given-names></name><name><surname>Fabiani</surname><given-names>E.</given-names></name><name><surname>Heier</surname><given-names>M.</given-names></name><name><surname>McMillan</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.</article-title>
<source><italic>Ann. Med.</italic></source>
<volume>42</volume>
<fpage>587</fpage>&#x02013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.3109/07853890.2010.505931</pub-id>
<?supplied-pmid 21070098?><pub-id pub-id-type="pmid">21070098</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadal</surname><given-names>I.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Imbalance in the composition of the duodenal microbiota of children with coeliac disease.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>56</volume>
<fpage>1669</fpage>&#x02013;<lpage>1674</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.47410-0</pub-id>
<?supplied-pmid 18033837?><pub-id pub-id-type="pmid">18033837</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Behare</surname><given-names>P. V.</given-names></name><name><surname>Jain</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Probiotics, their health benefits and applications for developing healthier foods: a review.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>334</volume>
<fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2012.02593.x</pub-id>
<?supplied-pmid 22568660?><pub-id pub-id-type="pmid">22568660</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nistal</surname><given-names>E.</given-names></name><name><surname>Caminero</surname><given-names>A.</given-names></name><name><surname>Vivas</surname><given-names>S.</given-names></name><name><surname>Ruiz de Morales</surname><given-names>J. M.</given-names></name><name><surname>Saenz de Miera</surname><given-names>L. E.</given-names></name><name><surname>Rodriguez-Aparicio</surname><given-names>L. B.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients.</article-title>
<source><italic>Biochimie</italic></source>
<volume>94</volume>
<fpage>1724</fpage>&#x02013;<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2012.03.025</pub-id>
<?supplied-pmid 22542995?><pub-id pub-id-type="pmid">22542995</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojeda</surname><given-names>P.</given-names></name><name><surname>Bobe</surname><given-names>A.</given-names></name><name><surname>Dolan</surname><given-names>K.</given-names></name><name><surname>Leone</surname><given-names>V.</given-names></name><name><surname>Martinez</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology.</article-title>
<source><italic>J. Nutr. Biochem.</italic></source>
<volume>28</volume>
<fpage>191</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2015.08.013</pub-id>
<?supplied-pmid 26372091?><pub-id pub-id-type="pmid">26372091</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><name><surname>Varea</surname><given-names>V.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of <italic>Bifidobacterium longum</italic> CECT 7347 in children with newly diagnosed coeliac disease.</article-title>
<source><italic>Br. J. Nutr.</italic></source>
<volume>112</volume>
<fpage>30</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114514000609</pub-id>
<?supplied-pmid 24774670?><pub-id pub-id-type="pmid">24774670</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Laparra</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Oral administration of <italic>Bifidobacterium longum</italic> CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model.</article-title>
<source><italic>J. Proteomics</italic></source>
<volume>77</volume>
<fpage>310</fpage>&#x02013;<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2012.09.005</pub-id>
<?supplied-pmid 23023000?><pub-id pub-id-type="pmid">23023000</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Neef</surname><given-names>A.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><name><surname>Palma</surname><given-names>G. D.</given-names></name><name><surname>Varea</surname><given-names>V.</given-names></name><name><surname>Capilla</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.</article-title>
<source><italic>Gut</italic></source>
<volume>64</volume>
<fpage>406</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2014-306931</pub-id>
<?supplied-pmid 24939571?><pub-id pub-id-type="pmid">24939571</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papista</surname><given-names>C.</given-names></name><name><surname>Gerakopoulos</surname><given-names>V.</given-names></name><name><surname>Kourelis</surname><given-names>A.</given-names></name><name><surname>Sounidaki</surname><given-names>M.</given-names></name><name><surname>Kontana</surname><given-names>A.</given-names></name><name><surname>Berthelot</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics.</article-title>
<source><italic>Lab. Invest.</italic></source>
<volume>92</volume>
<fpage>625</fpage>&#x02013;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2012.13</pub-id>
<?supplied-pmid 22330344?><pub-id pub-id-type="pmid">22330344</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellerin</surname><given-names>L.</given-names></name><name><surname>Jenks</surname><given-names>J. A.</given-names></name><name><surname>B&#x000e9;gin</surname><given-names>P.</given-names></name><name><surname>Bacchetta</surname><given-names>R.</given-names></name><name><surname>Nadeau</surname><given-names>K. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Regulatory T cells and their roles in immune dysregulation and allergy.</article-title>
<source><italic>Immunol. Res.</italic></source>
<volume>58</volume>
<fpage>358</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1007/s12026-014-8512-5</pub-id>
<?supplied-pmid 24781194?><pub-id pub-id-type="pmid">24781194</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Holzman</surname><given-names>I. R.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>61</volume>
<fpage>37</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1203/01.pdr.0000250014.92242.f3</pub-id>
<?supplied-pmid 17211138?><pub-id pub-id-type="pmid">17211138</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo-Rubio</surname><given-names>T.</given-names></name><name><surname>de Palma</surname><given-names>G.</given-names></name><name><surname>Mujico</surname><given-names>J. R.</given-names></name><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Marcos</surname><given-names>A.</given-names></name><name><surname>Acuna</surname><given-names>M. D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the proficel study.</article-title>
<source><italic>Nutr. Hosp.</italic></source>
<volume>28</volume>
<fpage>464</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.3305/nh.2013.28.2.6310</pub-id>
<?supplied-pmid 23822699?><pub-id pub-id-type="pmid">23822699</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo-Rubio</surname><given-names>T.</given-names></name><name><surname>Olivares</surname><given-names>M.</given-names></name><name><surname>Nova</surname><given-names>E.</given-names></name><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Mujico</surname><given-names>J. R.</given-names></name><name><surname>Ferrer</surname><given-names>M. D.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Immune development and intestinal microbiota in celiac disease.</article-title>
<source><italic>Clin. Dev. Immunol.</italic></source>
<volume>2012</volume>:<issue>654143</issue>. <pub-id pub-id-type="doi">10.1155/2012/654143</pub-id>
<?supplied-pmid 23008734?><pub-id pub-id-type="pmid">23008734</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raha</surname><given-names>O.</given-names></name><name><surname>Sarkar</surname><given-names>B.</given-names></name><name><surname>Lakkakula</surname><given-names>B. V.</given-names></name><name><surname>Pasumarthy</surname><given-names>V.</given-names></name><name><surname>Godi</surname><given-names>S.</given-names></name><name><surname>Chowdhury</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India.</article-title>
<source><italic>J. Biomed. Sci.</italic></source>
<volume>20</volume>:<issue>12</issue>. <pub-id pub-id-type="doi">10.1186/1423-0127-20-12</pub-id>
<?supplied-pmid 23441825?><pub-id pub-id-type="pmid">23441825</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishna</surname><given-names>B. S.</given-names></name><name><surname>Makharia</surname><given-names>G. K.</given-names></name><name><surname>Chetri</surname><given-names>K.</given-names></name><name><surname>Dutta</surname><given-names>S.</given-names></name><name><surname>Mathur</surname><given-names>P.</given-names></name><name><surname>Ahuja</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Prevalence of adult celiac disease in india: regional variations and associations.</article-title>
<source><italic>Am. J. Gastroenterol.</italic></source>
<volume>111</volume>
<fpage>115</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2015.398</pub-id>
<?supplied-pmid 26729543?><pub-id pub-id-type="pmid">26729543</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>Curiel</surname><given-names>J. A.</given-names></name><name><surname>Nionelli</surname><given-names>L.</given-names></name><name><surname>Vincentini</surname><given-names>O.</given-names></name><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>Silano</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Use of fungal proteases and selected sourdough lactic acid bacteria for making wheat bread with an intermediate content of gluten.</article-title>
<source><italic>Food Microbiol.</italic></source>
<volume>37</volume>
<fpage>59</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2013.06.017</pub-id>
<?supplied-pmid 24230474?><pub-id pub-id-type="pmid">24230474</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzello</surname><given-names>C. G.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><name><surname>Di Cagno</surname><given-names>R.</given-names></name><name><surname>Camarca</surname><given-names>A.</given-names></name><name><surname>Silano</surname><given-names>M.</given-names></name><name><surname>Losito</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>73</volume>
<fpage>4499</fpage>&#x02013;<lpage>4507</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00260-07</pub-id>
<?supplied-pmid 17513580?><pub-id pub-id-type="pmid">17513580</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanos</surname><given-names>J.</given-names></name><name><surname>van Diemen</surname><given-names>C. C.</given-names></name><name><surname>Nolte</surname><given-names>I. M.</given-names></name><name><surname>Trynka</surname><given-names>G.</given-names></name><name><surname>Zhernakova</surname><given-names>A.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>137</volume>
<fpage>834</fpage>&#x02013;<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.05.040</pub-id>
<?supplied-pmid 19454285?><pub-id pub-id-type="pmid">19454285</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>J. L.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2009</year>). <article-title>The gut microbiota shapes intestinal immune responses during health and disease.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>9</volume>
<fpage>313</fpage>&#x02013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1038/nri2515</pub-id>
<?supplied-pmid 19343057?><pub-id pub-id-type="pmid">19343057</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Capilla</surname><given-names>A.</given-names></name><name><surname>Nova</surname><given-names>E.</given-names></name><name><surname>Pozo</surname><given-names>T.</given-names></name><name><surname>Castillejo</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by <italic>Bacteroides</italic> species.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>77</volume>
<fpage>5316</fpage>&#x02013;<lpage>5323</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00365-11</pub-id>
<?supplied-pmid 21642397?><pub-id pub-id-type="pmid">21642397</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Intestinal <italic>Bacteroides</italic> species associated with coeliac disease.</article-title>
<source><italic>J. Clin. Pathol.</italic></source>
<volume>63</volume>
<fpage>1105</fpage>&#x02013;<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.2010.076950</pub-id>
<?supplied-pmid 20972239?><pub-id pub-id-type="pmid">20972239</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Donat</surname><given-names>E.</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C.</given-names></name><name><surname>Fernandez-Murga</surname><given-names>M. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Duodenal-mucosal bacteria associated with celiac disease in children.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>79</volume>
<fpage>5472</fpage>&#x02013;<lpage>5479</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00869-13</pub-id>
<?supplied-pmid 23835180?><pub-id pub-id-type="pmid">23835180</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Laparra</surname><given-names>J. M.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Discerning the role of <italic>Bacteroides</italic> fragilis in celiac disease pathogenesis.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>78</volume>
<fpage>6507</fpage>&#x02013;<lpage>6515</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00563-12</pub-id>
<?supplied-pmid 22773639?><pub-id pub-id-type="pmid">22773639</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>Y.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Marzotto</surname><given-names>M.</given-names></name><name><surname>Calabuig</surname><given-names>M.</given-names></name><name><surname>Torriani</surname><given-names>S.</given-names></name><name><surname>Dellaglio</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis.</article-title>
<source><italic>FEMS Immunol. Med. Microbiol.</italic></source>
<volume>51</volume>
<fpage>562</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00337.x</pub-id>
<?supplied-pmid 17919298?><pub-id pub-id-type="pmid">17919298</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapone</surname><given-names>A.</given-names></name><name><surname>De Magistris</surname><given-names>L.</given-names></name><name><surname>Pietzak</surname><given-names>M.</given-names></name><name><surname>Clemente</surname><given-names>M. G.</given-names></name><name><surname>Tripathi</surname><given-names>A.</given-names></name><name><surname>Cucca</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.</article-title>
<source><italic>Diabetes Metab. Res. Rev.</italic></source>
<volume>55</volume>
<fpage>1443</fpage>&#x02013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.2337/db05-1593</pub-id>
<?supplied-pmid 16644703?><pub-id pub-id-type="pmid">16644703</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savvateeva</surname><given-names>L. V.</given-names></name><name><surname>Gorokhovets</surname><given-names>N. V.</given-names></name><name><surname>Makarov</surname><given-names>V. A.</given-names></name><name><surname>Serebryakova</surname><given-names>M. V.</given-names></name><name><surname>Solovyev</surname><given-names>A. G.</given-names></name><name><surname>Morozov</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Glutenase and collagenase activities of wheat cysteine protease Triticain-alpha: feasibility for enzymatic therapy assays.</article-title>
<source><italic>Int. J. Biochem. Cell Biol.</italic></source>
<volume>62</volume>
<fpage>115</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2015.03.001</pub-id>
<?supplied-pmid 25765959?><pub-id pub-id-type="pmid">25765959</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulzke</surname><given-names>J. D.</given-names></name><name><surname>Bentzel</surname><given-names>C. J.</given-names></name><name><surname>Schulzke</surname><given-names>I.</given-names></name><name><surname>Riecken</surname><given-names>E. O.</given-names></name><name><surname>Fromm</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>43</volume>
<fpage>435</fpage>&#x02013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199804000-00001</pub-id>
<?supplied-pmid 9544995?><pub-id pub-id-type="pmid">9544995</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuppan</surname><given-names>D.</given-names></name><name><surname>Junker</surname><given-names>Y.</given-names></name><name><surname>Barisani</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Celiac disease: from pathogenesis to novel therapies.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>137</volume>
<fpage>1912</fpage>&#x02013;<lpage>1933</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.09.008</pub-id>
<?supplied-pmid 19766641?><pub-id pub-id-type="pmid">19766641</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellitto</surname><given-names>M.</given-names></name><name><surname>Bai</surname><given-names>G.</given-names></name><name><surname>Serena</surname><given-names>G.</given-names></name><name><surname>Fricke</surname><given-names>W. F.</given-names></name><name><surname>Sturgeon</surname><given-names>C.</given-names></name><name><surname>Gajer</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e33387</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033387</pub-id>
<?supplied-pmid 22432018?><pub-id pub-id-type="pmid">22432018</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senapati</surname><given-names>S.</given-names></name><name><surname>Gutierrez-Achury</surname><given-names>J.</given-names></name><name><surname>Sood</surname><given-names>A.</given-names></name><name><surname>Midha</surname><given-names>V.</given-names></name><name><surname>Szperl</surname><given-names>A.</given-names></name><name><surname>Romanos</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Evaluation of European coeliac disease risk variants in a north Indian population.</article-title>
<source><italic>Eur. J. Hum. Genet.</italic></source>
<volume>23</volume>
<fpage>530</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2014.137</pub-id>
<?supplied-pmid 25052311?><pub-id pub-id-type="pmid">25052311</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senger</surname><given-names>S.</given-names></name><name><surname>Luongo</surname><given-names>D.</given-names></name><name><surname>Maurano</surname><given-names>F.</given-names></name><name><surname>Mazzeo</surname><given-names>M. F.</given-names></name><name><surname>Siciliano</surname><given-names>R. A.</given-names></name><name><surname>Gianfrani</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice.</article-title>
<source><italic>Immunol. Lett.</italic></source>
<volume>88</volume>
<fpage>127</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-2478(03)00069-5</pub-id>
<?supplied-pmid 12880682?><pub-id pub-id-type="pmid">12880682</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serena</surname><given-names>G.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Camhi</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Lima</surname><given-names>R. S.</given-names></name><name><surname>Sapone</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Proinflammatory cytokine interferon-gamma and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease.</article-title>
<source><italic>Clin. Exp. Immunol.</italic></source>
<volume>187</volume>
<fpage>490</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12911</pub-id>
<?supplied-pmid 27936497?><pub-id pub-id-type="pmid">27936497</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serjeantson</surname><given-names>S. W.</given-names></name><name><surname>Ranford</surname><given-names>P. R.</given-names></name><name><surname>Kirk</surname><given-names>R. L.</given-names></name><name><surname>Kohonen-Corish</surname><given-names>M. R.</given-names></name><name><surname>Mohan</surname><given-names>V.</given-names></name><name><surname>Ramachandran</surname><given-names>A.</given-names></name><etal/></person-group> (<year>1987</year>). <article-title>HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India.</article-title>
<source><italic>Dis. Mark.</italic></source>
<volume>5</volume>
<fpage>101</fpage>&#x02013;<lpage>108</lpage>. <?supplied-pmid 2901931?><pub-id pub-id-type="pmid">2901931</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamir</surname><given-names>R.</given-names></name><name><surname>Lerner</surname><given-names>A.</given-names></name><name><surname>Shinar</surname><given-names>E.</given-names></name><name><surname>Lahat</surname><given-names>N.</given-names></name><name><surname>Sobel</surname><given-names>E.</given-names></name><name><surname>Bar-or</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors.</article-title>
<source><italic>Am. J. Gastroenterol.</italic></source>
<volume>97</volume>:<issue>2589</issue>. <pub-id pub-id-type="doi">10.1111/j.1572-0241.2002.06028.x</pub-id>
<?supplied-pmid 12385444?><pub-id pub-id-type="pmid">12385444</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Marti</surname><given-names>T.</given-names></name><name><surname>Sollid</surname><given-names>L. M.</given-names></name><name><surname>Gray</surname><given-names>G. M.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.</article-title>
<source><italic>Biochem. J.</italic></source>
<volume>383</volume>
<fpage>311</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20040907</pub-id>
<?supplied-pmid 15245330?><pub-id pub-id-type="pmid">15245330</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Molberg</surname><given-names>O.</given-names></name><name><surname>Parrot</surname><given-names>I.</given-names></name><name><surname>Hausch</surname><given-names>F.</given-names></name><name><surname>Filiz</surname><given-names>F.</given-names></name><name><surname>Gray</surname><given-names>G. M.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Structural basis for gluten intolerance in celiac sprue.</article-title>
<source><italic>Science</italic></source>
<volume>297</volume>
<fpage>2275</fpage>&#x02013;<lpage>2279</lpage>. <pub-id pub-id-type="doi">10.1126/science.1074129</pub-id>
<?supplied-pmid 12351792?><pub-id pub-id-type="pmid">12351792</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevach</surname><given-names>E. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Foxp3+T regulatory cells: still many unanswered questions a perspective after 20 years of study.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>9</volume>:<issue>1048</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01048</pub-id>
<?supplied-pmid 29868011?><pub-id pub-id-type="pmid">29868011</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shmidt</surname><given-names>E.</given-names></name><name><surname>Smyrk</surname><given-names>T. C.</given-names></name><name><surname>Boswell</surname><given-names>C. L.</given-names></name><name><surname>Enders</surname><given-names>F. T.</given-names></name><name><surname>Oxentenko</surname><given-names>A. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Increasing duodenal intraepithelial lymphocytosis found at upper endoscopy: time trends and associations.</article-title>
<source><italic>Gastrointest. Endosc.</italic></source>
<volume>80</volume>
<fpage>105</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.gie.2014.01.008</pub-id>
<?supplied-pmid 24565068?><pub-id pub-id-type="pmid">24565068</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoaie</surname><given-names>S.</given-names></name><name><surname>Ghaffari</surname><given-names>P.</given-names></name><name><surname>Kovatcheva-Datchary</surname><given-names>P.</given-names></name><name><surname>Mardinoglu</surname><given-names>A.</given-names></name><name><surname>Sen</surname><given-names>P.</given-names></name><name><surname>Pujos-Guillot</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Quantifying diet-induced metabolic changes of the human gut microbiome.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>22</volume>
<fpage>320</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.001</pub-id>
<?supplied-pmid 26244934?><pub-id pub-id-type="pmid">26244934</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>M.</given-names></name><name><surname>Bethune</surname><given-names>M. T.</given-names></name><name><surname>Gass</surname><given-names>J.</given-names></name><name><surname>Ehren</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Johannsen</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Rational design of combination enzyme therapy for celiac sprue.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>13</volume>
<fpage>649</fpage>&#x02013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2006.04.009</pub-id>
<?supplied-pmid 16793522?><pub-id pub-id-type="pmid">16793522</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Arora</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Strand</surname><given-names>T. A.</given-names></name><name><surname>Makharia</surname><given-names>G. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence of celiac disease in Asia: a systematic review and meta-analysis.</article-title>
<source><italic>J. Gastroenterol. Hepatol.</italic></source>
<volume>31</volume>
<fpage>1095</fpage>&#x02013;<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1111/jgh.13270</pub-id>
<?supplied-pmid 26678020?><pub-id pub-id-type="pmid">26678020</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singla</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Rohtagi</surname><given-names>A.</given-names></name><name><surname>Choudhury</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>HLA profile of celiac disease among first-degree relatives from a tertiary care center in North India.</article-title>
<source><italic>Indian J. Pediatr.</italic></source>
<volume>83</volume>
<fpage>1248</fpage>&#x02013;<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1007/s12098-016-2146-7</pub-id>
<?supplied-pmid 27264101?><pub-id pub-id-type="pmid">27264101</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjoberg</surname><given-names>V.</given-names></name><name><surname>Sandstrom</surname><given-names>O.</given-names></name><name><surname>Hedberg</surname><given-names>M.</given-names></name><name><surname>Hammarstrom</surname><given-names>S.</given-names></name><name><surname>Hernell</surname><given-names>O.</given-names></name><name><surname>Hammarstrom</surname><given-names>M. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria.</article-title>
<source><italic>PLoS One</italic></source>
<volume>8</volume>:<issue>e53414</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0053414</pub-id>
<?supplied-pmid 23326425?><pub-id pub-id-type="pmid">23326425</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smecuol</surname><given-names>E.</given-names></name><name><surname>Hwang</surname><given-names>H. J.</given-names></name><name><surname>Sugai</surname><given-names>E.</given-names></name><name><surname>Corso</surname><given-names>L.</given-names></name><name><surname>Chernavsky</surname><given-names>A. C.</given-names></name><name><surname>Bellavite</surname><given-names>F. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Exploratory, randomized, double-blind, placebo-controlled study on the effects of <italic>Bifidobacterium</italic> infantis natren life start strain super strain in active celiac disease.</article-title>
<source><italic>J. Clin. Gastroenterol.</italic></source>
<volume>47</volume>
<fpage>139</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1097/MCG.0b013e31827759ac</pub-id>
<?supplied-pmid 23314670?><pub-id pub-id-type="pmid">23314670</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollid</surname><given-names>L. M.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Future therapeutic options for celiac disease.</article-title>
<source><italic>Nat. Clin. Pract. Gastroenterol. Hepatol.</italic></source>
<volume>2</volume>
<fpage>140</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1038/ncpgasthep0111</pub-id>
<?supplied-pmid 16265155?><pub-id pub-id-type="pmid">16265155</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollid</surname><given-names>L. M.</given-names></name><name><surname>Markussen</surname><given-names>G.</given-names></name><name><surname>Ek</surname><given-names>J.</given-names></name><name><surname>Gjerde</surname><given-names>H.</given-names></name><name><surname>Vartdal</surname><given-names>F.</given-names></name><name><surname>Thorsby</surname><given-names>E.</given-names></name></person-group> (<year>1989</year>). <article-title>Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.</article-title>
<source><italic>J. Exp. Med.</italic></source>
<volume>169</volume>
<fpage>345</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1084/jem.169.1.345</pub-id>
<?supplied-pmid 2909659?><pub-id pub-id-type="pmid">2909659</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Yachha</surname><given-names>S. K.</given-names></name><name><surname>Mathias</surname><given-names>A.</given-names></name><name><surname>Parveen</surname><given-names>F.</given-names></name><name><surname>Poddar</surname><given-names>U.</given-names></name><name><surname>Agrawal</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Prevalence, human leukocyte antigen typing and strategy for screening among Asian first-degree relatives of children with celiac disease.</article-title>
<source><italic>J. Gastroenterol. Hepatol.</italic></source>
<volume>25</volume>
<fpage>319</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.06044.x</pub-id>
<?supplied-pmid 19929927?><pub-id pub-id-type="pmid">19929927</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>C.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Van Sinderen</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Fermented functional foods based on probiotics and their biogenic metabolites.</article-title>
<source><italic>Curr. Opin. Biotechnol.</italic></source>
<volume>16</volume>
<fpage>198</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2005.02.008</pub-id>
<?supplied-pmid 15831387?><pub-id pub-id-type="pmid">15831387</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepniak</surname><given-names>D.</given-names></name><name><surname>Spaenij-Dekking</surname><given-names>L.</given-names></name><name><surname>Mitea</surname><given-names>C.</given-names></name><name><surname>Moester</surname><given-names>M.</given-names></name><name><surname>de Ru</surname><given-names>A.</given-names></name><name><surname>Baak-Pablo</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.</article-title>
<source><italic>Am. J. Physiol. Gastrointest. Liver Physiol.</italic></source>
<volume>291</volume>
<fpage>G621</fpage>&#x02013;<lpage>G629</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00034.2006</pub-id>
<?supplied-pmid 16690904?><pub-id pub-id-type="pmid">16690904</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturgeon</surname><given-names>C.</given-names></name><name><surname>Fasano</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.</article-title>
<source><italic>Tissue Barriers</italic></source>
<volume>4</volume>:<issue>e1251384</issue>. <pub-id pub-id-type="doi">10.1080/21688370.2016.1251384</pub-id>
<?supplied-pmid 28123927?><pub-id pub-id-type="pmid">28123927</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suez</surname><given-names>J.</given-names></name><name><surname>Korem</surname><given-names>T.</given-names></name><name><surname>Zeevi</surname><given-names>D.</given-names></name><name><surname>Zilberman-Schapira</surname><given-names>G.</given-names></name><name><surname>Thaiss</surname><given-names>C. A.</given-names></name><name><surname>Maza</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Artificial sweeteners induce glucose intolerance by altering the gut microbiota.</article-title>
<source><italic>Nature</italic></source>
<volume>514</volume>
<fpage>181</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/nature13793</pub-id>
<?supplied-pmid 25231862?><pub-id pub-id-type="pmid">25231862</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teresi</surname><given-names>S.</given-names></name><name><surname>Crapisi</surname><given-names>M.</given-names></name><name><surname>Vallejo</surname><given-names>M. D.</given-names></name><name><surname>Castellaneta</surname><given-names>S. P.</given-names></name><name><surname>Francavilla</surname><given-names>R.</given-names></name><name><surname>Iacono</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Celiac disease seropositivity in Saharawi children: a follow-up and family study.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>50</volume>
<fpage>506</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e3181bab30c</pub-id>
<?supplied-pmid 20639708?><pub-id pub-id-type="pmid">20639708</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>K. E.</given-names></name><name><surname>Sapone</surname><given-names>A.</given-names></name><name><surname>Fasano</surname><given-names>A.</given-names></name><name><surname>Vogel</surname><given-names>S. N.</given-names></name></person-group> (<year>2006</year>). <article-title>Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease.</article-title>
<source><italic>J. Immunol.</italic></source>
<volume>176</volume>
<fpage>2512</fpage>&#x02013;<lpage>2521</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2512</pub-id>
<?supplied-pmid 16456012?><pub-id pub-id-type="pmid">16456012</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuire</surname><given-names>I.</given-names></name><name><surname>Marja-Leena</surname><given-names>L.</given-names></name><name><surname>Teea</surname><given-names>S.</given-names></name><name><surname>Katri</surname><given-names>H.</given-names></name><name><surname>Jukka</surname><given-names>P.</given-names></name><name><surname>Paivi</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.</article-title>
<source><italic>Am. J. Gastroenterol.</italic></source>
<volume>107</volume>
<fpage>1563</fpage>&#x02013;<lpage>1569</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2012.220</pub-id>
<?supplied-pmid 22825364?><pub-id pub-id-type="pmid">22825364</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Wal</surname><given-names>Y.</given-names></name><name><surname>Kooy</surname><given-names>Y. M.</given-names></name><name><surname>van Veelen</surname><given-names>P.</given-names></name><name><surname>Vader</surname><given-names>W.</given-names></name><name><surname>August</surname><given-names>S. A.</given-names></name><name><surname>Drijfhout</surname><given-names>J. W.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Glutenin is involved in the gluten-driven mucosal T cell response.</article-title>
<source><italic>Eur. J. Immunol.</italic></source>
<volume>29</volume>
<fpage>3133</fpage>&#x02013;<lpage>3139</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199910)29:10&#x0003c;3133::AID-IMMU3133&#x0003e;3.0.CO;2-G</pub-id>
<?supplied-pmid 10540324?><pub-id pub-id-type="pmid">10540324</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wacklin</surname><given-names>P.</given-names></name><name><surname>Laurikka</surname><given-names>P.</given-names></name><name><surname>Lindfors</surname><given-names>K.</given-names></name><name><surname>Collin</surname><given-names>P.</given-names></name><name><surname>Salmi</surname><given-names>T.</given-names></name><name><surname>Lahdeaho</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet.</article-title>
<source><italic>Am. J. Gastroenterol.</italic></source>
<volume>109</volume>
<fpage>1933</fpage>&#x02013;<lpage>1941</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2014.355</pub-id>
<?supplied-pmid 25403367?><pub-id pub-id-type="pmid">25403367</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Uzzau</surname><given-names>S.</given-names></name><name><surname>Goldblum</surname><given-names>S. E.</given-names></name><name><surname>Fasano</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Human zonulin, a potential modulator of intestinal tight junctions.</article-title>
<source><italic>J. Cell Sci.</italic></source>
<volume>113</volume>(Pt 24), <fpage>4435</fpage>&#x02013;<lpage>4440</lpage>.<pub-id pub-id-type="pmid">11082037</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>L. E.</given-names></name><name><surname>Bannerman</surname><given-names>E.</given-names></name><name><surname>McGrogan</surname><given-names>P.</given-names></name><name><surname>Kastner-Cole</surname><given-names>D.</given-names></name><name><surname>Carnegie</surname><given-names>E.</given-names></name><name><surname>Gillett</surname><given-names>P. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Childhood coeliac disease diagnoses in Scotland 2009-2010: the SPSU project.</article-title>
<source><italic>Arch. Dis. Child.</italic></source>
<volume>98</volume>
<fpage>52</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2012-302056</pub-id>
<?supplied-pmid 23184350?><pub-id pub-id-type="pmid">23184350</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Chemistry of gluten proteins.</article-title>
<source><italic>Food Microbiol.</italic></source>
<volume>24</volume>
<fpage>115</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2006.07.004</pub-id>
<?supplied-pmid 17008153?><pub-id pub-id-type="pmid">17008153</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamakhchari</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Dewhirst</surname><given-names>F.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Schuppan</surname><given-names>D.</given-names></name><name><surname>Oppenheim</surname><given-names>F. G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e24455</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0024455</pub-id>
<?supplied-pmid 21957450?><pub-id pub-id-type="pmid">21957450</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ruan</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A diet with lactosucrose supplementation ameliorates trinitrobenzene sulfonic acid-induced colitis in rats.</article-title>
<source><italic>Food Funct.</italic></source>
<volume>6</volume>
<fpage>162</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1039/c4fo00381k.</pub-id>
<?supplied-pmid 25367079?><pub-id pub-id-type="pmid">25367079</pub-id></mixed-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list id="DL1"><def-item><term>AN-PEP</term><def><p><italic>Aspergillus niger</italic> prolyl endoprotease</p></def></def-item><def-item><term>Caco-2</term><def><p>Colorectal Adenocarcinoma</p></def></def-item><def-item><term>CD</term><def><p>Celiac Disease</p></def></def-item><def-item><term>GFD</term><def><p>Gluten Free Diet</p></def></def-item><def-item><term>HCs</term><def><p>Healthy Controls</p></def></def-item><def-item><term>HLA</term><def><p>human leukocyte antigen</p></def></def-item><def-item><term>HMW-GS</term><def><p>High molecular weight-glutenin subunits</p></def></def-item><def-item><term>LAB</term><def><p>Lactic Acid Bacteria</p></def></def-item><def-item><term>mTG</term><def><p>Microbial transglutaminase</p></def></def-item><def-item><term>PEP</term><def><p>Prolyl Endoprotease</p></def></def-item><def-item><term>T-CD</term><def><p>Treated-CD</p></def></def-item><def-item><term>TLR</term><def><p>Toll-like Receptor</p></def></def-item><def-item><term>U-CD</term><def><p>Untreated-CD</p></def></def-item></def-list></glossary></back></article>